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ABSTRACT 
The widespread emergence of muki-antibiotic resistant bacteria has increased the 
need for alternatives to conventional antibiotic therapy. Accordingly, a significant amount of 
effort has been made to investigate the potential use of bacteriophages as prophylactic and 
therapeutic agents for bacterial infections. In this study, molecular biological techniques 
were applied to construct a iysogen of lytic bacteriophage X in an attempt to combat with 
multi-antibiotic resistant bacteria by a novel method of lytic phage delivery. 
To accomplish this goal, two plasmid-based site-specific recombination (SSR) 
systems for integration and recovery of DNA constructs from Escherichia coli and 
Salnumella typhimurium chromosomes were developed. The two systems are mediated by 
SSR machineries of bacteriophages X. of £1 coli and P22 of S. typhimurium. These systems 
utilize plasmid vectors with conditional replicating origin of replication and provide stable 
chromosomal integration of genes at specific bacteriophage attachment sites without 
disruption of any host gene or a need for antibiotic selection. E. coli contains attachment 
sites for both bacteriophages. When the two systems are applied consecutively, two different 
genes can be integrated at two specific locations. The integrated plasmids of both systems 
can also be completely excised and recovered fi'om the host chromosomes to observe any 
genetic changes, e.g. by DNA sequencing. Both systems are also very applicable in 
construction of bacterial strains as well as live E. coli and S. typhimurium recombinant 
vaccines expressing foreign genes of interest. 
To construct a Iysogen of lytic bacteriophage X, both SSR systems were applied. A 
lytic mutant {ct) of bacteriophage X was marked with an antibiotic resistant gene cassette to 
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facilitate a lysogen selection. The P22 SSR system helped integrate functional X repressor 
gene (cT) into a non-pathogenic KcoU strain and the marked lytic X phage lysogenized in the 
presence of the helper plasmid of the X. SSR system. The lysogen demonstrated its efficacy 
in decreasing number of X sensitive Exoli. This lytic phage lysogen construction strategy 
can be applied for other bacteriophages. A pool of different lysogens infects a wider range of 
bacteria and could be utilized as alternatives to the use of antibiotics to control bacterial 
infections. 
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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
The widespread emergence of multiple antibiotic resistant pathogenic bacterial strains 
such as in Escherichia coli, Skphylococcus Streptococcus Pseuikmonas sp., etc., 
has become a significant problem in treating bacterial infections of humans and animals. 
Clearly, the need to identify alternatives to the use of antibiotics to control bacterial 
pathogens is becoming necessary. One suggested solution is the use of virulent 
bacteriophages (Barrow et ai, 1998). Bacteriophages are bacterial viruses that are able to 
infect specific bacterial species. Virulent phages lyse their host cells while temperate phages 
have the ability to either lyse the bacterial cells they infect or integrate into the host 
chromosome and form a lysogen. A population of lysogens will, however, continue to 
release progeny phages into the environment. These phage progeny will then repeat the 
infection cycle in their specific host species. 
Since the bacteriophages were discovered in 1915 (Twort, 1915) and in 1917 
(D'H^elle, 1917), a significant amount of effort has been made to investigate the potential 
use of bacteriophages as prophylactic and therapeutic agents against bacterial infections. In 
the first 30 years after the discovery of bacteriophages, the experimental designs of most 
research contained inadequate controls and the resuhs did not provide confident conclusions. 
The lade of understanding of the nature of bacteriophages also contributed to the variable 
success in bacteriophage therapy research. When antibiotics and sulfonamides were 
discovered in the 1940s, the interest in bacteriophage therapy dropped dramatically. It was 
not until multi-drug resistant bacteria and nosocomial infections increased significantly after 
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antibiotic usage that researchers turned their interests to the potential use of bacteriophages 
as an alternative to the use of antibiotics. 
More recent attempts to use bacteriophages as therapeutic agents in both humans and 
animals have been applied with some success to treat a wide variety of antibiotic resistant 
pathogens (for a review see Alisky et ai, 1998). For example, Smith and Muggins (1982) 
treated E. co//-infected mice using phages. They reported the superiority of phage therapy 
over antibiotics by demonstrating that a single intramuscular dose of the phages was more 
effective than multiple intramuscular doses of various antibiotics in curing mice of a 
potentially lethal induced infection of E. coli. This report inspired a new era of 
bacteriophage therapy researches both in human and veterinary medicine. 
In medical applications, Slopek et al. (1981-1987) reported a series of results from 
both topical and oral administration of phage therapy in humans with 92.4% clinical 
improvement but also with certain side effects such as gastrointestinal intolerance after oral 
administration and allergic symptoms upon local application. Cislo etal. (1987) studied the 
effect of concomitant topical and oral phage therapy on infectious skin ulcers, with a high 
rate of outstanding results along with similar side effects seen with oral treatment. Soothill 
(1994) successfully applied bacteriophage BS24 to control Pseudomonas aeruginosa 
contamination of bum wounds that caused failure in skin isografting. In veterinary 
applications. Smith and Huggins (1982) performed several animal experiments to 
demonstrate the efficacy of bacteriophage therapy using mixed phages. The effectiveness of 
phages was reported in treating K co/i-induced diarrhea in piglets and lambs (Smith and 
Huggins, 1983), and in calves (Smith etal, 1987). 
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Menil et al. (1996) enhanced the therapeutic efficacy of selected bacteriophages by 
isolating bacteriophage mutants that were able to remain in the circulatory system for 
prolonged periods of time during serial passage in mice. These long-circulating 
bacteriophages were shown to have a greater capability as antibacterial agents than the 
corresponding parent strains in treating animals infected with lethal doses of bacteria. One of 
the most recent bacteriophage applications utilized lytic R phage, previously isolated from 
sewage. These phages attached to the K1 capsular antigen and prevented septicemia and a 
meningitis-like infection in chickens and calves caused by a Kl'^ bacteremic strain ofK coli 
(Barrow et aL 1998). These researchers reported promising results even when phages were 
inoculated intramuscularly after the animals showed signs of disease. 
Bacteriophage therapy, however, has certain limitations. These limitations include 
the narrow specific host-range of bacteriophages, the ability of temperate phages to form 
lysogens, the sensitivity of bacteriophages to gastric acid when used in vivo and the lack of a 
continuous phage supply. When a temperate phage forms a lysogen in target bacteria, the 
lysogen then becomes immune to further phage infection and continues to proliferate in the 
presence of the phage. The sensitivity of bacteriophages to acid lysis requires gastric acid 
neutralization prior to oral treatment. The lack of a continuous supply of bacteriophages over 
the period of progressive bacterial infection may also contribute to the variable success of 
bacteriophage therapy. 
The objective of this study is to develop an effective lytic bacteriophage delivery 
system, as an alternative to antibiotics, that overcomes some major bacteriophage therapy 
limitations. Molecular biological techniques were applied to construct a lysogen of lytic 
bacteriophages X in a non-pathogenic £1 coli strain. The lysogen will continuously release 
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lytic bacteriophage X directly in the intestinal tract. In order to construct the lytic X lysogen, 
two plasmid-based site-specific recombination (SSR) systems for the integration and 
recovery of DNA constructs from E. coli and Salmonella typhinmrium chromosomes were 
developed. The two systems were mediated by site-specific recombination machineries of 
bacteriophages X of E. coli and P22 of S. typhimurium and demonstrated to be efficient in 
integrating DNA constructs into their respective bacteriophage attachment sites on the 
bacterial chromosomes. Both SSR systems were applied to lysogenize a lytic bacteriophage 
\ mutant marked with an antibiotic resistant gene cassette into a non-pathogenic E. coli 
strain. The enterobacterial origin of this lytic bacteriophage lysogen encodes acid-regulated 
genes which provide tolerance in low pH environment (Hickey and Hirshfield, 1990) and can 
be administered orally with no requirement for gastric acidity neutralization. The lysogen 
also provides a continuous supply of lytic bacteriophage that is incapable of lysogen 
formation in the target bacteria. The efficiency of the lytic A. lysogen in decreasing number 
of susceptible bacteria in vitro was demonstrated. 
Dissertation Organization 
This dissertation is organized into five chapters. The first chapter contains the 
general introduction and the literature review. Three papers to be submitted to scholarly 
journals follow. The first paper (Chapter 2), "Genetic system for reversible integration of 
DNA constructs and UkZ gene fusions into the Escherichia coli chromosome" was published 
in PUtsmids 2000 43:12-23. The second paper (Chapters 3), "Reversible integration of DNA 
constructs into the chromosomes of E. coli and S. typhimurittm by a bacteriophage P22 
mediated site-specific recombination system," is to be submitted to Journal of 
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Bacteriology. These first two papers describe the development of genetic tools to integrate a 
gene of interest into bacterial chromosomes. These genetic tools were applied to construct 
lytic bacteriophage lysogens in the third paper (Chapter 4), "Bacteriophage therapy; A novel 
method of lytic bacteriophage delivery". The contents of the second paper were presented in 
a poster session (Session 44/H19) of the 99*'* General Meeting of the American Society of 
Microbiology in Chicago, on May 31, 1999. Chapter S presents the general conclusions of 
the research. 
Literature Review 
Ackermann and Dubow (1987) reviewed in great detail a wide scope of bacteriophage 
research firom 1917 to 1987 in Viruses of Prokaryotes. Barrow and Soothill (1997) examined 
the rediscovery and renewed assessment of the potential of bacteriophage therapy in the post­
antibiotic period. The review, "Bacteriophages show promise as antimicrobial agents," by 
Alisky et al. (1998) presented detailed information on bacteriophage therapy fi'om 1966 to 
1996. 
Discovery of bacteriophages 
Bacteriophages are bacterial viruses that were first discovered in 1915 fi-om 
Staphylococcus sp. by a British bacteriologist, Frederick William Twort (Twort, 1915), and 
independently in 1917 Scorn Shigella (fysenteriM by a Canadian medical bacteriologist, F^lix 
Ibibert d'H^lle (D'H^elle, 1917). These discoveries opened a new area in microbiology 
research (cited in Duckworth, 1976). D'H^elle named the invisible microbe that was an 
obligate parasite of living bacteria he found "a bacteriophage" or by the shortened term 
"phage" and devoted the remainder of his scientific life conducting bacteriophage research. 
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The therapeutic potential of phages was also realized early on by d'Herelle who laid the 
foundation for experimental phage work. After the first discovery, d'Herelle found several 
additional phages from various bacterial species, including Salmonella typhi, BcKilltts 
subtilis, Corynebacterium cHphtheriae, Escherichia coli, Pasteurella multocida. Vibrio 
cholerae, and Yersinia pestis. Since then, several researchers have reported discoveries of 
other new phages from a wide range of bacterial hosts and in the soil and water of the 
environment. By 1935, phages of many major human bacterial pathogens, mostly the 
enterobacteria and Gram-positive cocci, were discovered (Ackermann and Dubow, 1987). 
General characteristics of bacteriophages 
Bacteriophages are bacterial viruses that are able to infect specific bacterial species. 
Similar to other viruses, they are obligate parasites that are able to replicate only in living 
cells. A phage particle usually consists of a single nucleic acid molecule which may be 
single-stranded or double-stranded, linear or circular DNA, or single-stranded, linear RNA. 
The three major morphological classes of the phages are icosahedral, icosahedral tailed, and 
filamentous. Bacteriophages have a specific host range because they require specific 
receptors on the host cell surface to bind and initiate an infection. 
Fundamental research of bacteriophages provided basic understanding of their 
physical and biological properties. Elford and Andrews (1932) used filters of graded pore 
size to determine the sizes of some phages. Burnett (1933) used particle size and host range 
of phages as well as resistance testing to subdivide enterobacterial phages into subgroups. 
Schlesinger (1933) purified phages by centrifugation. Ellis and Delbruck (1939) performed a 
one-step-growth experiment and introduced precise quantitative methods for bacteriophages. 
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Bacteriophages have two distinct life cycles, lytic and lysogenic. In the lytic cycle, 
bacteriophages utilize the host cells' replication machinery and precursors to produce nuuiy 
phage particles, then end the cycle by lysing the host cells. In the lysogenic cycle, no 
progeny particles are produced and the phage DNA usually becomes part of the bacterial 
chromosome by site-specific recombination. Examples of lysogenic phage include A. of K 
coli and P22 of S. typhimurium. Bacteriophage PI of K coli, alternatively exists in its 
lysogenic state as an episomal plasmid. The decision whether to utilize lytic or lysogenic 
growth depends on several factors, including the expression of the phage repressor and the 
nutritional status of the host. A phage capable only of lytic growth is called a virulent phage 
while a phage capable of both lytic and lysogenic growth is called a temperate phage. The 
bacterial host that contains a complete set of phage DNA in the chromosome is called a 
lysogen. Some prophages in a population of lysogens may switch to the lytic growth cycle 
and continue to release small amount of progeny phages into the environment. The progeny 
phages will then repeat the infection cycle in their susceptible host. 
Lytic veraus lysogenic cycle 
When temperate phages such as \ and P22 infect their hosts, phage DNA is injected 
into the bacteria and phage replication begins using the host replication machinery. A 
temperate phage must enter one of two cycles after the infection, the lytic or the lysogenic 
cycle. If the phage enters the lytic cycle, various sets of phage genes turn on and off under a 
precisely regulated program to facilitate the phage DNA replication. New structural proteins 
are synthesized and new phage particles are formed within the bacterium. In the case of 
bacteriophage X, within 45 minutes after infection the phage lyses the bacterium and releases 
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approximately 100 progeny phage particles. If the phage enters the lysogenic cycle, only one 
phage gene, the repressor gene, is turned on and a single phage DNA molecule integrates into 
the host chromosome by the phage-coded site-specific recombination system. When a 
lysogen grows and divides, the prophage is passively replicated and distributed to the 
progeny bacteria as a part of the chromosome and rarely produces progeny phages (Ptashne, 
1986). A lysogen is generally quite stable and can replicate nearly indeflnitely without 
release of phage. However, the prophage is able to enter the lytic cycle, lyse the host cell, 
and produce progeny phages when induced by agents that damage the host DNA such as 
ultraviolet light. The activation of the RecA protein of the SOS bacterial DNA repair system 
inactivates the phage repressor and causes the switch from lysogenic to lytic growth (Roberts 
etal. 1978). 
History of bacteriophage research 
Initially, the therapeutic potential of phages against bacterial infections in humans and 
animals received great attention as a research target. By 1940, before the first antibiotic was 
discovered, as many as 560 papers on phage therapy researches were published. Research in 
the basic biology of bacteriophage, including phage typing, lysogeny, genetics and 
biochemistry also attracted great interest during the period of 1940 to 1965. In 1950, for 
example, Lwoff and Gutmann described the nature of lysogens that cany "prophages" or 
phages in a non-infectious stage and pass them on to daughter cells for several passages 
(LwofF and Gutmann, 1990). Lwoff et ai (1950) reported prophage induction by UV light 
and, in 1953, published the entire concept of phage lysogeny. 
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Bacteriophages research also resulted in two significant discoveries into the nature of 
genetic information. In 1952, bacteriophage T2 served as a model for Hershey and Chase to 
study the role of DNA and confirmed that DNA, and not protein, was the genetic material 
(Hershey and Chase, 1952). Watson and Crick, in 1953, published their famous discovery of 
the double helix structure of DNA by the x-ray crystallography experiment using T-even 
phage DNA. They demonstrated that the DNA configuration consisted of two antiparallel 
strands of polynucleotide wound around each other and the backbone of each strand 
consisted of alternating deoxyribose and phosphate groups (Watson and Crick, 1953). In 
1959, Brenner and Home introduced the thin sectioning and negative staining technique for 
electron microscopy which led to significant advances in phage ultrastructure and genetic 
research thus enabling researchers to gain a much better understanding of phage biology, 
identification and classification (Brenner and Home, 1959). Electron microscopy also led to 
the extensive research of tailed phages and new phage groups, e.g., filamentous (M series) 
and pleomorphic (PM2) phages (Hofschneider, 1963, Marvin and HofTmann-Berling, 1963, 
Zinder et ai, 1963, Espejo and Canero, 1968). During this era, the search for new phages 
was constant. The phages of enterobacteria became the most known group and the majority 
of phage research was on coliphages. However, Gardner and Weiser discovered a 
Mycobacterium phage in 1947 (Gardner and Weiser, 1947), and in 1970 Gourlay isolated the 
Mycoplasma phage (Gourlay 1970). Currently, phages are known to exist in virtually all 
prokaiyotes (Ackermann and Dubow, 1987). 
10 
Application of bacteriophages 
Bacteriophages have been utilized extensively in molecular genetics ever since they 
were first discovered in 191S and 1917. They are used as tools for biotechnology, e.g., 
cloning vectors for foreign DNA (Blattner et al., 1977, Benton and Davis, 1977, Enquist, 
1980), or as specialized transducing phages (Miller, 1972, Glass, 1982). Bacteriophages 
were instrumental in the discovery and characterization of bacterial restriction and 
RKxlification systems (Arber, 1974). DNA sequencing was made possible by using 
bacteriophages (Sanger, 1977, Messing e/a/., 1981, Messing and Vieira, 1982). 
Bacteriophages have yielded useful enzymes for molecular cloning (Dugaiczyk et aL, 1975, 
Lobban and Kaiser, 1973, Maxam and Gilbert, 1977). Promoters from various phages have 
been used to study gene expression and regulation (Maniatis et aL, 1982, Studier, 1973), and 
for biotechnological applications (Denarie et aL, 1977, Faelen et aL, 1977, Casadaban et aL, 
1977). 
Phages have served as test objects for virucidal products (Drulak et al., 1979, Lepage 
and Romond, 1984, Menzel, 1984), and as indicators of bacterial pollution (Kenard and 
Valentine, 1974, Scarpino, 1971, Scarpino, 197S). They have been useful in the study of 
droplet infection (Colvin, 1932), the assay of air filters (Kewitsch, 1964), and in aerosol 
samplers (Morris et aL, 1961, Harstad, 1965). Phages have been useful as tracers of water 
currents (Drury and Wheeler, 1982), ground and main water (Niemi, 1976), and waste water 
movement (Salkinoja-Salonen et aL, 1981). 
In microbiological applications, bacteriophages have been utilized as diagnostic 
reagents (Sonnenschein, 1925, Cherry e/a/., 1954, Seeliger and Holl, 1961, Welkos«/a/., 
1974). Bacteria can be identified by phage typing (Schmidt and Jeffiries, 1975, Engel, 1978; 
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Kasatiya and Nicolle, 1978). Phages have also helped to detect specific bacteria (Katznelson 
and Sutton, 1951, Cook and Katznelson, 1960, Sutton, 1966), and in bacterial taxonomy 
(Keogh et al.^ 1938, Fisk, 1942, Conn et al., 1945). Phages have also been used for 
decontamination of bacteria from vaccines (Janzen and Wolff, 1922), tissue culture (Riche et 
al., 1978), or meat (Greer, 1986). The identification of potential carcinogens and antitumor 
antibiotics by prophage induction (Heinemann and Howard, 1964, Moreau ei al., 1976, 
Moreau and Devoret, 1977) has provided simple, less expensive, and more rapid tests than 
the use of laboratory animals and cell cultures. Bacteriophage therapy and prophylaxis of 
infectious bacterial diseases in both man and animals have been widely practiced with 
optimistic results (Smith and Huggins, 1982-1983, Slopek et al., 1983-1985, Barrow et al., 
1998). 
Despite the advantages offered by bacteriophages, they can be harmful as well. For 
example, in the fermentation industry, harmful phages are those which contaminate the 
process. These phages also became a major problem in the dairy industry, causing 
considerable economic losses by destroying starter cultures and disrupting fermentation 
(Whitehead and Cox, 1935, Babel, 1962; Klaenhammer, 1984, Lawrence a/., 1976, 
Lawrence and Thomas, 1979). Other industries using bacteria for fermentation have 
experienced losses from phage contamination as well (Hongo, 1971, Ogata and Hongo, 1979, 
Ogata, 1980). 
Pre-antibiotic bacteriophage therapy research 
Before antibiotics, bacteriophages were perceived as a possible panacea to prevent 
and control bacterial infectious diseases in both humans and animals. Since the first 
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bacteriophage was discovered until 1965, some 900 papers on phage therapy research were 
published, with the highest peak of activity from 1930 to 1940. In 1921, the treatment of 
staphylococcal skin disease with phages initiated immediate widespread interest (Bruynoghe 
and Maisin, 1921). D'Herelle, the medical bacteriologist who also independently discovered 
bacteriophage, used phages to treat plague bubos in Egypt in 192S (D'Herelle, 1925), and 
cholera in India in 1928 (D'Herelle, 1928). Human diseases for which bacteriophage therapy 
was applied included pyogenic and urinary infections, cholera, dysentery, plague, typhoid 
and paratyphoid fevers, as well as phage prophylaxis of intestinal infections. Phage 
administration covered almost every route possible, including the intra-carotid artery and 
direct injection into lung tissue (Raettig, 1958, Raettig, 1967). 
Phage therapy during that period resulted in a wide range of results, from spectacular 
successes to failures which led to a greater understanding of the nature and limitation of 
phages. The causes of the failures included the narrow host range of a particular phage and a 
specific phage was needed to treat a specific bacterial infection. If an infection was caused 
by mixed bacterial infection one phage could not stop the infection, rather a mixture of 
different phages specific to each bacterial pathogen was required. The emergence of phage 
resistant bacteria was also possible through the selection of mutants. Furthermore, lysogen 
of a temperate phage became immune to the superinfection with the same phage and was 
able to perpetuate the infection. Bacteriophages themselves were sensitive to acid lysis if 
administered orally, without prior neutralization of gastric pH. 
The inactivation of phages by body defense mechanisms and antiseptics from skin 
lesion treatment also contributed to the failure of phage therapy. One significant, serious 
adverse effect from bacteriophage-mediated bacterial cell lysis was the liberation of 
13 
endotoxin that could cause a septic shock. The major weakness of bacteriophage therapy 
during the pre-antibiotic period was mainly due to the many unknown factors involved. 
Sometimes, unknown phages at unspecified titers were used to treat patients without prior 
bacteriological diagnosis, proper controls or placebos. Interpretations of treatments did not 
inspire confidence and large clinical studies were rarely reported. These circumstances, 
together with the discoveries of antibiotics and sulfonamides in the 1940s, resulted in a 
dramatic decline in phage therapy research. In 1959, the World Health Organization (WHO) 
concluded that there was no reason to continue investigations on the use of bacteriophage to 
control Vibrio cholerae infection because tetracycline therapy was successful (Pollitzer, 
1959). 
Post-antibiotic bacteriophage therapy research 
The widespread emergence of antibiotic resistant bacteria and the discovery of 
antibiotic residues in food animals revived the interest in bacteriophage therapy to control 
long-term bacterial infection. Several research studies were conducted in both medical and 
veterinary settings. During this era, more careful selection of the specific phages, controls, 
and treatment protocols were applied. Most reports now have showed promising resuhs that 
encourage further experimentation into the application of bacteriophage therapy. 
Medical applications 
Slopek et al (1981-1987) reported a series of results from both topical and oral 
administration of phage therapy in humans in Poland, mainly against postoperative or 
spontaneous infections by antibiotic resistant Staphylococcus, Salmonella, Klebsiella, 
Escherichia, Proteus, and Pseudomonas. Oral administration was applied in cases of 
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gastrointestinal and generalized infections, with the repeated high doses of phages after 
gastric acidity neutralization. Positive results indicated clinical improvement without a 
proper control or an untreated group. However, side effects of oral phage treatment such as 
allergic symptoms and vomiting were also reported. Cislo et al. (1987) studied the effect of 
concomitant topical and oral phage therapy on infectious skin ulcers, with a high rate of 
positive results along with side effects similar to those seen with oral treatment. Weber-
Dabrowska et al. (1987) reported the penetration of orally administered phages into the 
circulatory system and in urine. Kucharewicz-Krukowska and Slopek (1987) analyzed the 
antibody response of patients receiving oral phage therapy and found that most patients 
(77%) did not develop antiphage antibodies whereas some (14%) did at low levels, and only 
4% generated high antibody titers. They concluded that this degree of immunogenicity did 
not interfere with phage treatment. More recently, Soothill (1994) successfully applied 
bacteriophage BS24 to control Pseudomonas aeruginosa contamination of bum wounds that 
caused failure in skin isografting. 
Veterinary applications 
Smith and Huggins (1982) performed several animal experiments to demonstrate the 
efficacy of bacteriophage therapy. They treated experimentally E. co//-infected mice using 
mixed phages. They reported the superiority of the phage therapy over antibiotics by 
showing that a single intramuscular dose of the phages was more effective than multiple 
intramuscular doses of various antibiotics in curing mice of a potentially lethal, induced 
infection with E. coli. Notably, the few phage-resistant mutants of E. coli found in the mice 
were shown to be of greatly reduced virulence. 
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The effectiveness of phages was reported in treating E. co//-induced diarrhea in 
piglets and Iambs (Smith and Huggins, 1983), and in calves (Smith etaL, 1987). It was 
observed that the phages multiplied rapidly after gaining entry to the K co/i-infected small 
intestine and quickly reduced the numbers of E. coli to levels that were virtually harmless. 
Merril et al. (1996) enhanced the therapeutic efficacy of selected bacteriophages by 
serial passage in mice and isolating bacteriophage mutants that were able to remain in the 
circulatory system for prolonged periods of time. These 'long-circulating' bacteriophages 
were shown to have a greater capability as antibacterial agents than the corresponding parent 
strains in animals infected by lethal doses of bacteria. 
One of the most recent bacteriophage applications utilized lytic R phage, previously 
isolated from sewage. These phages attached to the K1 capsular antigen and prevented 
septicemia and a meningitis-like infection in chickens and calves caused by a K1+ 
bacteremic strain of E. coli. Barrow et al. (1998) reported promising results even when 
phages were intramuscularly inoculated after the animals showed signs of disease. 
X and P22 phages 
The two best-studied temperate phages are bacteriophage X of E. coli and P22 of S. 
typhimurium. Bacteriophage X. is classified in the family Siphoviridae while P22 is in the 
Podoviridae. Both phages are well characterized genetically and although they belong to 
different families, they are closely related. The regions concerned with regulation, 
recombination, host integration, DNA replication, and lysis functions of both phages are 
arranged in the same order on their respective genetic maps. The phages also share major 
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DNA sequence homology and can even form viable hybrid phage when parts of P22 phage 
are replaced by analogous X genes (Botstein and Herskowitz, 1974). 
Although the two phages share these similarities they are clearly distinct from each 
other. For example, P22 DNA is packed in the phage head with direct sequence repeats at 
each end (Casjens et al.^ 1987) which recombine by homologous recombination to form a 
circular DNA molecule which is needed for rolling-circle replication (Rhoades et al., 1968). 
The X DNA contains single-stranded cohesive end to circularize in vivo (Campbell, 1971). 
Morphologically, P22 has only a short baseplate structure and adsorbs only to S. typhimurium 
whereas X. has an elongated tail and adsorbs only to E coli (Kellenberger and Edgar, 1971). 
The control of the lysogeny of P22 is based on two regions essential for immunity and 
repression. P22 lysogens exclude superinfecting phages in ways extending beyond the 
immunity and repression system (Chan and Botstein, 1972). The \ phage has only one 
region for lysogeny control and the lysogens display solely the immunity provided by the 
single repressor protein to protect themselves from superinfection (Rao, 1968, Campbell, 
1971, Susskind etal., 1971). 
Repressor systems of A. and P22 phages 
In either a X. or P22 lysogen, the only phage gene that is expressed is the repressor 
gene (c/ of A. and c2 of P22). The repressor protein regulates phage gene expression by 
interaction with specific operator sites that overlap with the promoters for the repressor and 
cro genes. Repressor protein facilitates lysogenic growth while Cro protein does the lytic 
cycle. 
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Oiti Or2 OR\ 
Figure 1.1 Right operator region of bacteriophage X. 
As shown in Figure 1.1, the cl repressor and Cro proteins (transcnoed from PR) have 
their own promoters adjacent to each other with the transcripts diverging to opposite 
directions. There are three adjacent operator sites that overlap both promoters. The repressor 
and Cro proteins bind these sites with different affmities to regulate the activities of the two 
promoters. The repressor protein binds to its high affmity operator site Or\ that overlaps the 
PR promoter. The binding of cl at OrI interferes with RNA polymerase binding and 
represses the transcription of Cro. The cooperative binding of cl repressors at OrI and Or2 
also facilitates RNA polymerase binding at cl promoter. When the repressor protein cl 
accumulates, it also binds the low affinity operator site Or2 that overlaps its own promoter 
and turns ofif the transcription by autoregulation (Ptashne, 1986). 
By binding to prophage operators, the repressor protein turns off all the phage genes 
required for lytic growth. As many as 100 copies of repressor protein are expressed in a 
lysogen (Ptashne, 1986). This number of repressor protein molecules provides immunity to 
the lysogen against superinfection by the same phage by binding to the operators of the 
newly introduced phage DNA and turning off all genes for phage replication. Factors that 
inactivate the repressor protein, such as activated RecA protein, will derepress the prophage 
genes and initiates the lytic growth cycle of the prophage (Ptashne, 1986). 
18 
The importance of the repressor gene in iysogeny was determined by isolation of lytic 
mutants of A. and P22 phages. The so-called clear plaque mutants encode non-functional 
repressor protein and therefore cannot establish lysogens and are always lytic to the host 
cells. These phage mutants grow lytically in any susceptible host but not in the lysogens of 
the same phage, since functional repressor protein encoded by prophages can repress the lytic 
growth of these lytic phages. Another type of clear plaque mutant resulted from mutations in 
the operator sequences recognized by the repressor protein. These mutants are unable to be 
repressed by functional repressor proteins and, consequently, can overcome superinfection 
immunity. 
Site-specific recombination systems of X. and P22 phages 
Site-specific recombination is a strategy used by a variety of temperate 
bacteriophages to lysogenize their hosts by reversibly integrating their DNA into the hosts' 
chromosomes. The characteristics of site-specific recombination are that it is site-specific, 
reciprocal, conservative, and does not involve DNA replication at the recombination site 
(Neidhardt et al., 1987), plus it does not require homologous recombination. In general, 
bacteriophages use the Int protein together with the integration host factor (IHF) of the host 
to recognize attachment sites of the phage DNA and the bacterial chromosome, to promote 
integration of the phage DNA. (Lindsey et al., 1992). Excision of a phage from a lysogen 
requires both the Int and Xis proteins to initiate the recombination event (Leong et al., 1985). 
To form a lysogen in their host cells, temperate phages integrate their DNA into the 
host chromosomes. The specific attachment sites of each phage are different but share some 
common features including a high A+T composition. The attachment sites on both the 
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bacterial chromosome and the phages, as well as the resulting attachment sites, attL and attR  ^
share conunon core sequences where recombination takes place. Bacteriophage X has a IS-
base pair while P22 has a 46-base pair common core. The core sequences of the two phages 
show no significant homology but there are dispersed regions of homology in the arm 
sequences that indicate that both att sites are related (Leong et al., 1985). The integration 
host factor (IHF) binding sites of K coii in both phages are different, but the location and 
orientation of the binding sites in relation to the respective core regions are well conserved. 
In the X system, the IHF interacts with three regions on the attP and none on attB (Craig and 
Nash, 1984). The IHF binds to a site to the left of the common core in the P22 phage att site 
{attP) and to a site to the right of the core in the P22 attP and bacterial att site {attP22). The 
IHF has a significant role in X SSR but is not required in the P22 system. Cho et ai (1999) 
demonstrated that although the attP region of P22 contained strong IHF binding sites, P22 
phage performed site-specific recombination to its maximum efficiency in the absence of 
IHF. 
In addition to the use of bacteriophage for a number of applications, specific phage 
genes have also been exploited as useful genetic tools. Specifically, the efficiency of 
bacteriophage site-specific recombination has been utilized in a number of plasmid-based 
systems to integrate various genes into host chromosomes at specific attachment sites. For 
example, systems have been developed that use phage Mx8 in Myxococcus xanthus (Li and 
Shimkets, 1988), phage HPl in Haemt^hilus influenzae (Goodman and Scocca, 1989, 
Hauser and Scocca, 1992), pSAM2 in Streptomyces lividans (Smokvina et 1990), in 
Kfycobacterium smegmatis (Martin et al., 1991), and in Mycobacterium leprae (Eiglmeier et 
aLy 1991X mycobacteriophage LS xn Kfycobacterium smegmatis, Mycobacterium 
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tuberculosis^  and bacille Calmette-Guerin (BCG) (Lee et al.^  1991), phage phi adh in 
Lactobacillus gasseri (Rayae/a/., 1992), phage 16-3 in Rhizobium meliloti 41 (Hennesze/ 
a/., 1992), phage Tuc2009 (van de Guchte et al., 1994), phage mv4 in Lactobacillus 
plantarum (Dupont et al., 1995), actinophage RP3 in Streptomyces rimosus (Gabriel et al., 
1995), phage phi CTX in Pseudomonas aeruginosa (Wang et al., 1995), phage phi AAU2 in 
Arthrobacter aureus (Le Marrec et al., 1996), phage T12 in Streptococcus pyogenes 
(McShan et al., 1997), phage phiLC3 (Lillehaug et al., 1997) and phage TP901-1 (Brondsted 
and Hammer, 1999) in Lactococcus lactis, phage A2 in Lactobacillus species, Lactococcus 
lactis, and K coli (Alvarez et al., 1998), phage SfX in Shigella flexneri (Guan and Verma, 
1998), phage P4 in Pseudomonas sp. (Ravatn et al., 1998), corynephage Phil6 in 
Corynebacterium glutamicum (Moreau et al., 1999), and X phage in E. coli (Atlung et al., 
1991, Diederich et al., 1992, Hasan et al., 1994, Piatt et al., 1999). The advantages of these 
systems include the ability to study gene functions from a single copy of gene. For example, 
when employing a reporter gene such as lacZ to monitor gene expression, the result can be 
misinterpreted as the plasmid copy number can change depending upon the specific growth 
conditions or the genetic background of the bacterial strain. The experimental result can also 
be influenced by an unnaturally high level of a regulatory protein or c/5-acting regulatory 
sequences present on the high copy number plasmids. Stable integration also obviates the 
need for continual antibiotic selection for the maintenance of the DNA construct. Moreover, 
integration at the specific A. phage attachment site assures that no functional host gene is 
inactivated. The system reported by Piatt et al. (1999) utilizes conditionally replicating 
R6Ky ori plasmids as vectors for integration and also makes it feasible to easily retrieve the 
entire integrated plasmid. The plasmid-based systems of A, SSR have been widely applied to 
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construct bacterial strains and characterize specific genes (Atlung et ai, 1991, Diederich et 
al., 1992, Hasan et al., 1994, Piatt etal., 2000, Lee ei al., 2000). This is also a promising 
model for future recombinant K coli vector vaccines expressing foreign antigens. 
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CHAPTER 2. GENETIC SYSTEM FOR REVERSIBLE INTEGRATION OF 
DNA CONSTRUCTS AND JL/ICZGENE FUSIONS INTO 
ESCHERICHIA COL/CHROMOSOME 
A paper published in Plasmid' 
Ratree Piatt, Christopher Drescher, Sei-Kyoung Park and Gregoiy J. Phillips 
ABSTRACT 
A plasmid system for site-specific integration into, and excision and recovery of gene 
constructs and lacZ gene fusions from the E. coli chromosome was developed. Plasmid 
suicide vectors utilizing the origin of replication of R6K plasmids and containing the attP 
sequence of bacteriophage X, multiple cloning site, and antibiotic resistance markers 
facilitate reversible integration into the Kcoli chromosome by site-specific recombination. 
Additional vectors permit construction of lacZ gene fusions in 3 possible reading frames for 
recombination with the bacterial chromosome. These suicide vectors can be propagated in 
newly constructed K coli strains that harbor different pir alleles. Two helper plasmids that 
encode the necessary gene products for integration (Int) and excision (Int and Xis) were also 
constructed. This plasmid system was shown to be a reliable and efficient means to integrate 
and subsequently recover plasmids from the Kcoli attB site. 
INTRODUCTION 
The characterization of specific genes in vivo often requires creation of recombinant 
DNA constructs that places a target gene under control of a regulatable promoter, or that 
fuses a gene to a reporter sequence to monitor gene expression. Generally, such DNA 
' Reprinted by permission of the publisher. (Copyright © 2000 by Academic Press) 
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constructs are introduced and maintained in K coli on multicopy plasmids. However, there 
can be disadvantages associated with the study and manipulation of gene function by the use 
of recombinant plasmids. For example, plasmid loss or rearrangement can occur if synthesis 
of a gene product is detrimental to cell growth. Recombinant plasmids may also be unstable 
and subsequently lost in the absence of continual selection. Likewise, results of experiments 
that employ a reporter gene, such as /acZ, to monitor gene expression can be misinterpreted 
as plasmid copy number can change depending upon the specific growth conditions, or 
genetic background of the bacterial strain. Moreover, experimental results can be influenced 
by unnaturally high level of a regulatory protein or cis-acting regulatory sequences present 
on high copy number plasmids. 
It is with these problems in mind that various genetic systems have been constructed 
for integration of DNA constructs into the E. coli chromosome. For example, a number of 
cloning vectors derived from bacteriophage X have been developed to integrate genes and 
gene fusions into the Exoli chromosome by specialized transduction (Howard and 
Gottesman, 1983; Bertrand etal., 1984; Windle, 1986; Balakrishnan and Backman, 1988; 
Koob and Szybalski, 1990; Linn and St. Pierre, 1990; St. Pierre and Linn, 1996; see also 
Murray, 1991; Slauch and Silhavy, 1991). However, direct cloning of genetic constructs into 
bacteriophage X. vectors requires the manipulation of large DNA molecules, often with a 
limited number of available restriction sites. The recombinant molecules must subsequently 
be packaged in vitro prior to introduction to an Kcoli host. Furthermore, the use of helper 
phage or plasmids are often required to generate a lysogen of the recombinant X vector 
Murray, 1991). 
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The assembly of specialized transducing phage can be aided by using specific X 
vectors that have significant regions of homology to plasmid vectors that carry a gene 
construct or fusion. Upon recombination with the X. DNA, the phage carrying the gene 
construct can be introduced to the bacterial chromosome by lysogeny (Ostrow et al.^ 1986; 
Simon et ai, 1987). These systems require construction of a specific recombinant plasmid 
prior to recombination into the X vector. The large size of bacteriophage X vectors also limits 
the ease at which the DNA can be further manipulated or studied after it is recovered from 
the host chromosome. 
Additional systems have been described that make use of transposable elements to 
integrate DNA constructs into the bacterial chromosome (DeLorenzo et ai, 1990; Bao et al., 
1991; Alexeyev and Shokolenko, 1995; Peredelchuk and Bennett, 1997). A disadvantage of 
these approaches, however, is that the target for chromosomal insertion is not predictable as 
the transposable element can insert in a variety of locations. Further characterization of the 
insertion mutants is required to ensure that the transposable element has not altered the 
phenotype of the recipient strain. 
A number of plasmid-based systems have also been described for introduction of 
DNA constructs into the E. coii chromosome, many of which utilize the efficient site-specific 
recombination machinery of bacteriophage X to integrate DNA sequences into the bacterial 
attachment site for this phage (attB) (Atlung et al., 1991; Diederich et al., 1992; Hasan et ai., 
1994). In general, these plasmid-based systems first require creation of a circular DNA 
construct to be introduced to the bacterial chromosome. The construct must either be 
assembled in vitro (Atlung etal., 1991) or the origin of replication (on) must be removed 
from a recombinant plasmid, either by restriction enzyme digestion (Diederich et ai, 1992) 
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or by Cre-/ar-mediated recombination (Hasan et al., 1994) prior to chromosomal integration. 
These systems utilize a helper plasmid that provides the int gene product in trans. While 
retrieval of the DNA constructs from the chromosome is not possible with the former 
systems (Atlung et al., 1991; Diederich et al., 1992), the latter system (Hasan et al., 1994) 
requires the use of two helper plasmids to retrieve the integrated DNA. 
We report here a facile plasmid system for integration and recovery of DNA 
constructs from the E. coli chromosome that requires a minimal amount of manipulation for 
either integration or retrieval of the DNA constructs. The vectors described in this report 
utilize the K6K.yori to achieve conditional replication of the recombinant plasmids. The 
R6KYon forms the foundation for a number of suicide vectors that cannot replicate in the 
absence of n, the protein product of the pir gene (Kolter et al., 1978). We have constructed a 
series of RdKyon'-based plasmids that carry attP, the attachment site from bacteriophage X, a 
chloramphenicol resistance or spectinomycin resistance marker, and a multiple cloning site. 
Vectors have also been constructed to permit introduction of translational lacZ gene fusions 
to the chromosome. We show that these vectors faithfully integrated into the K coli attB site 
when provided the int gene product via a conditionally replicating helper plasmid. The entire 
vector can subsequently then be retrieved from the bacterial chromosome by use of a second 
helper plasmid that provided the Integrase (Int) and Excisionase (Xis) proteins. Together, 
these vectors comprise a genetic system that should be useful for a number of applications 
where it is advantageous to stably maintain genetic constructs, including lacZ gene fusions, 
in single copy and retain the ability to retrieve the construct if desired. They should also 
foster novel genetic approaches to study bacterial gene function (Haldimann et al., 1996). 
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MATERIALS AND METHODS 
Strains and plasmids 
Bacterial strains are listed in Table 1 and Table 2 lists the plasmids constructed in this 
study. 
Media and chemicab 
Luria-Bertani (LB) medium (Sambrook et ai, 1989) was used throughout the study. 
The concentrations of antibiotics were: ampicillin (Amp) 100 |ig/ml; chloramphenicol 
(Cam), 20 ^g/ml; kanamycin (Kan), 30 ^g/ml; spectinomycin (Spc), SO ^g/ml, and 
tetracycline (Tet), 20 ^g/ml. Bacterial cultures were grown at ITC unless otherwise 
indicated. S-bromo-4-chloro-3-indolyl P-D-galactopyranoside pC-gal) and isopropyl 3-D-
thiogalactopyranoside (IPTG) were used at concentrations of 1% and 1 mM, respectively. 
Techniques of recombinant DNA and bacterial genetics 
Standard techniques of recombinant DNA were performed (Sambrook e/a/., 1989) 
for construction of plasmids. Enzymes and reagents were obtained commercially and used 
according to the manufacturers' recommendations. Transformations were performed by 
either electroporation (Sheng et al., 199S) or chemical transformation (Inoue et al., 1990). 
Isolation of plasmid DNA was performed by a modification of the technique described by 
Carter and Milton (1993). Transductions with bacteriophage PI were performed as described 
by Miller (1992). DHSo /^r and DH5apirII6 were constructed by transducing zdg-
232::TnJ0 into BW19610 and BW19612. A PlWr lysate was prepared from the resulting 
strain and used to transduce DHSa that had been transformed with pRecATS (a plasmid with 
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temperature sensitive replication carrying recA*, (Park, S.-K. and G.J. Phillips, unpublished 
results). Tet*^ transductants were cultured at 42''C to eliminate the complementing plasmid. 
The resuhing transductants were screened for the ability to be transformed with pCDl IPKS 
by selection for Cam*^. 
Plasmid constructions 
Vectors for integration of DNA constructs into the E. colt chromosome include the 
Cam*^ plasmids pCDl IPKS and pCDl IPSK and the Spc*^ plasmids pCDISPKS and 
pCD13PSK. The former pair was constructed by introducing a 0.5 kb BamHl-Bgll attP-
containing fragment from pLDRl 1 (Diederich et ai^ 1992) into the R6Kyo/7 suicide vector, 
pCD20 (Park, S-K. and G.J. Phillips, manuscript in preparation). pLDRl 1 was first digested 
with EcdStl and Smal, treated with the Klenow fragment of DNA polymerase I, and religated 
to eliminate these restriction sites prior to insertion into pCD20. pCDlBPKS and pCD13PSK 
were constructed by replacing an 5!^I Cam*^ fragment from pCDl IPKS and pCDl IPSK with 
a 1.4 kb Dral fragment encoding Spc*^ from pKRP13 (Reece and Phillips, 199S). 
Vectors for construction and integration of lacZ gene fusions in three open reading 
frames (ORF) were made by first constructing a derivative of pCDl IPSK where the UkZ 
gene from pMLB1034 (Silhavy et al., 1984) was altered by site-specific mutagenesis to 
eliminate a SocI (£c/136II) site from within UkZ. A 3.2 kb Fspl fragment containing this 
modified lacZ was inserted into F^^^I-digested pCDl IPSK. The unique £:c/136n site on this 
vector was converted to an AatU site by addition of linkers. A1.5 kb AaiU. fragment from 
the vectors pLACZl, pLACZla, pLACZ2, and pLACZ3 (Jain, 1993) carrying the multiple 
cloning site and four tandem copies of the transcriptional terminator from the rmB operon 
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was exchanged for the conresponding region of DNA in this vector creating pCDl IPZl, 
pCDllPZla, pCDllPZ2, and pCDllPZS, respectively. 
The helper plasmids for integration, pPICK, was constructed by modifying a 1 kb 
iKs/UI fragment encoding n, originating from pcos2EMBL (Ehrich et al.^ 1987) to contain 
£coRI sites at each end by the addition of linkers and inserting it into a unique £coRI site of 
pLDR8 (Diederich et ai, 1992). pXINT129, the helper plasmid for production of Int and Xis 
proteins, was constructed by first cloning a 1 kb. EcoVil-Sacl fragment carrying xis from 
pPS2-3ARS (Numrych et al., 1992) into pSP0RT2 (Gibco, BRL, Gaithersburg, MD). A 
second pSP0RT2 derivative was also assembled by inserting a 2.3 kb Ecd'Bil-Pstl int 
fragment from pLDRS (Diederich et al., 1992). A 2.4 kb BspHl-Bsal fragment from this 
latter vector was cloned into the former xis* plasmid generating a construct where xis and int 
were under control of the repressor encoded by laci on pSP0RT2. A 1.4 kb HindUl Kan*^ 
cassette from pKRPl 1 (Reece and Phillips, 1995) was then introduced. A Sapl DNA 
fragment carrying ImI, xis, int, and encoding Kan*^ was then excised, treated with the 
Klenow fingment of DNA polymerase I and inserted into the unique HincU site of pNoTA 
(Five Prime, Three Prime, Inc., Boulder, CO). A 4.4 kb Pmel cassette was then excised from 
this plasmid and joined to F^^^I-digested pWSK29 (Wang and Kushner, 1991) creating 
pXINT129. 
Chromosomal integration of plasmid DNA 
The K coli strains MC4100 or DHSa served as hosts for plasmid integration. These 
strains were first transformed with the helper plasmid pPICK by selection for Kan*^ at SO'C. 
The temperature sensitive phenotype of pPICK was confirmed by showing that the 
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transformants were unable to form single colonies at ATC in the presence of Kan. The 
pPICK transformants were then transformed with various pCDl IP- or pCD13P-derivative 
plasmids by selection for Cam*^ or Spc^ respectively at VfC. Transformants were 
subsequently restreaked for Cam*^ or Spc*^ at Al^C. Colonies that arose after overnight 
incubation were twice again restreaked under the same growth conditions. Finally, 
antibiotic resistant colonies were screened for Kan^to confirm loss of pPICK. 
PGR assay for plasmid integration 
An approach similar to that reported by Powell et al. (1994) was used to confirm 
plasmid integration by site-specific recombination. A PGR primer pair was designed to 
amplify a 0.5 kb region flanking the attB site. The sequences of primer A and primer B were 
5'- GGGGGGGTGAATGGTGGTATG-3' (Tm = 57.3°G) and 5'-
GAGTGTGTGGGAAGGGGGTG.3' (Tm = Sg.S-G), respectively. Two additional PGR 
primers were designed to anneal to sequences within the pGDl IP- and pGD13P-derivative 
plasmids. The sequence of primer G was 5'-GTAATAATTGAGGATATGATGTGGG 
TAGG-3' (Tm = 56.1®G) and primer D was 5'-GGTGTTGGGGTTGGTGGGTG-3' (Tm = 
57.9''G). When primer B was paired with primer D in a PGR reaction a 1.1 kb product was 
obtained only if the pGDl IP- or pGD13P- derivative vector had correctly integrated into the 
bacterial chromosome at attB. Similarly, amplification with primers A and G yielded a 0.6 
kb PGR product. If the vectors had integrated by site-specific recombination in tandem, i.e., 
two copies of the plasmid integrated at attB, a 1.2 kb product fi'om the G-D primer pair was 
expected. PGR was performed on genomic DNA prepared by a commercial kit (Centra, Inc., 
Minneapolis, MN) with 25 cycles of 94°G, 55**G, and 72'*G for 30 seconds each using the 
Gene Amp PGR System 2400 (Peridn-Elmer, Foster Gity, G A). 
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Characterization of plasmid integration by PI transduction 
Fifty independently-isolated colonies of RPl 10, created by integrating pCDllPiS«;Z 
into the chromosome of MC4100, were chosen as recipients for bacteriophage Plv/r grown 
on the gal'76::TnJ0 strain N3030. The transductants were selected on LB+Tet plates and 
subsequently patched onto LB+Tet+X-gal plates. The patches were scored for blue or white 
color and then subsequently replica plated onto LB+Cam to score for loss of Cam*^. 
Retrieval of integrated plasmids 
The helper plasmid for excision, pXINT129, was transformed into RPl 10 by 
selection on LB+Kan+Cam plates. Six individual colonies were separately inoculated into 
six LB+Kan broth cultures. Each culture was then split into two tubes and IPTG was added 
to one of the tubes. After incubation at 2TC for 4 hours, plasmid DNA was prepared from 
one pair of cultures. The same procedure was repeated after growth for 5, 6, 7, and 8 hours 
and following overnight incubation. The plasmid DNA was then used to transform DHSq^ir 
by selection for Cam*^ in the presence of X-gal. The number of blue colonies arising from 
each transformation was recorded. RPl 10 served as a negative control for this experiment. 
RESULTS AND DISCUSSIONS 
Integration of plasmid DNA into the £ coU chromosome 
The development of a plasmid system for reversible integration of DNA constructs 
into the K coli chromosome required the use of vectors whose replication functions were 
conditionally. We have exploited the R6KYori to construct plasmid vectors whose 
replication is conditional on the presence of ic, a protein required to initiate replication of 
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plasmid R6K (Kolter et at., 1978). In the absence of TC, stable transformants of a plasmid 
utilizing R6KYori can be selected only if the plasmid integrates into the bacterial 
chromosome by recombination. As shown in Fig. 1, we have designed a series of RdKyori 
vectors to facilitate introduction of DNA constructs into the K coli chromosome by site-
specific recombination. These vectors cany, in addition to K6K.yori, the aitP site and impart 
resistance to Cam (pCDl IPKS and pCDl IPSK) or Spc (pCD13PKS and pCD13PSK). 
These plasmids, hereafter referred to as the "integration vectors," also carry the multiple 
cloning site from pBlueScript (Stratagene, La Jolla, CA) to facilitate cloning of insert DNA, 
and screening by blue/white colony color in the presence of X-gal. 
A series of integration vectors was also constructed to facilitate construction and 
introduction of lacZ gene fusions to the K coli chromosome. As shown in Fig. 2, these 
vectors contain the multiple cloning site described by Jain (1993) where fusions between a 
target gene and lacZ can be constructed in all possible ORFs. These vectors can also be 
modified to cany specific transcriptional fusions between a target gene and lacZ. 
The helper plasmid pPICK (Fig. 3) facilitates site-specific recombination of the 
integration vectors. This Kan*^ plasmid is a derivative of pLDRS (Diederich, et al., 1992) 
which expressed int under control of the c/«57 repressor and whose replication is also 
thermosensitive. This plasmid was modified to encodecreating pPICK, to enable 
cotransformation with the RdKyori integration vectors. Subsequent culturing of the doubly 
transformed cells at 42''C resuhs in loss of the helper plasmid, concomitant with 
synthesis of the X Int protein. Cam*^ colonies are selected and represent cells where the 
integration vectors have integrated by site-specific recombination. 
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To characterize the plasmid integration system we constructed a derivative of 
pCDl IPKS that encoded lacT. This plasmid, pCDl WlacZ, was used to convert various 
UkZ mutants, including MC4100 and DHSo, to lacZ^ and, therefore, was useful for a number 
of tests of the site-specific recombination system, as described below. 
Characterization of integrated DNA 
Fig. 4A shows the configuration of an integration plasmid that has been introduced to 
the E. coli chromosome by site-specific recombination. Also shown are the locations of PCR 
primers used to probe the resuhs of an integration event. Fig. 4B shows the results of a PCR 
assay used to confirm integration of a pCDl IP- vector into attB. PCR amplification of a 
prospective pCDl IP- integrant in MC4100 yielded a 1.1 kb product from primers A-D, and a 
0.6 kb product from primers B-C, while no product from the A-B primer pair was obtained. 
The MC4100 control yielded, as expected, a O.S kb band representing the intact attB site with 
primers A-B, but no product from either A-D or B-C primer pairs. Tandem plasmid 
integration was not detected using the C-B primer pair from any of the ten integrants tested. 
These results were consistent with the integration of a single copy of pCDl IP/acZ into attB 
ofMC4100. 
To determine if pCDl IflacZ had integrated at multiple sites on the £ coli 
chromosome, i.e., at attB and at one of a number of secondary att sites (Shimada and 
Weisber, 1972; Shimada et al., 1973), a genetic test using bacteriophage PI transduction was 
performed. We reasoned that transducing an af/0;;pCDl IP/acZ host with a PI lysate 
prepared from ugahTnJO donor should result in loss of Cam*^ and lacZ*' at a frequency 
representing the tight linkage between gal::TnJO and attB. We anticipated that greater than 
90% of the Tet*^ transductants should have lost the integrated plasmid, as revealed by their 
44 
Cam^ phenotype and white colony color on X-gal, if pCDl WlacZ resided only at attB. 
Conversely, transductants where pCDllPibcZhad integrated at another chromosomal 
location, unlinked to galvJnlO^ should remain Cam*^ and blue on X-gal. The results of the 
transduction experiments revealed that out of SO independent transductants of RPl 10,100% 
showed linkage to galvUnlO, i.e. all of the Tet*^ transductants became Cam^ and LacZ* at a 
frequency that reflected the tight linkage between gal and attB. This observation led us to 
conclude that out of SO independently derived integrants of pCDl IP/acZ, all originated from 
an integration event exclusively at attB. 
Construction of pir* hosts 
A number of E. coli strains have been constructed that incorporate pir, the structural 
gene encoding n, into their chromosome permitting propagation ofKSKyori vectors (Simon 
etal., 1983; Metcalfe/a/., 1994). To improve the efficiency of selecting and analyzing 
recombinants of the integration plasmids we modified DHSa by incorporating two pir alleles 
into its chromosome. These pir derivative strains were constructed using DHSa as this strain 
is efficiently transformed with plasmid DNA, supports a-complementation for blue/white 
screening of recombinants, and yields ample quantities of high quality plasmid. DHSqp/r is 
pir*, and TMSapirlI6 carries pir 116, a mutant version ofpir that leads to increased copy 
number of RfiKyon' plasmids (Greener et al., 1990). This latter strain is useful for preparing 
large quantities of the integration vectors, while the pir* derivative should be useful for 
cloning genes that may be toxic to the host when overexpressed. 
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Retrieval of integrated plasmids 
Genetic strategies such as isolation of regulatory mutants can provide a powerful 
approach to understanding gene expression and fiinction. The plasmid integration system 
described here can facilitate isolation and characterization of mutants by providing a means 
to introduce genes or gene fusions in diploid, or to introduce heterologous sequences into the 
K coli chromosome, and then to recover the sequences following mutagenesis (Haldimann et 
ai, 1996). To retrieve the integration plasmids fi'om the chromosome the Kan*^ helper 
plasmid pXINT129 was constructed. Retrieval of pCDl \?lacZ was accomplished by 
transformingRPllO with pXINT129, isolating plasmid DNA after culturing the 
transformants for varying times and retransforming into DHSo^/r. Table 3 shows that 
pCDl l?lacZ was retrieved fi'om the pXINT129 transformants at all growth times tested, 
while no plasmid was retrieved from cells that were not transformed with pXINT129. We 
routinely recover integrated plasmid DNA by culturing pXINT129 transformants in the 
presence of Kan and IPTG for 4 hrs. prior to isolation of plasmid DNA and subsequent 
transformation into DHSo^/r or DHSo^irl 16. 
Plasmids retrieved by excision fi-om the K coli chromosome were shown to be 
identical to the plasmids prior to integration. Essentially all of the DH5qpir transformants 
were LacZ^, and no evidence of rearrangements or other alterations to pCDl WlacZ was 
observed following digestion with a number of restriction enzymes (data not shown). 
Plasmids that undergo a complete cycle of integration and retrieval apparently do so 
unaltered. 
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Homologous recombination vs. site-specific recombination 
We have used the plasmid integration to construct partial diploid strains by 
integrating a second copy of an E. coli gene at attB. In a recA* background, such as 
MC4100, we predicted that antibiotic resistant recombinants would also arise due to 
homologous recombination, in addition to site-specific recombination. Indeed, when 
integrating a pCDl IPKS-derivative plasmid carrying a 2.0 kb insert with homology to the K 
coli chromosome, we observed that up to 50% of the Cam*^ transformants arose by 
homologous recombination (data not shown). We found this class of transformant to be 
relatively easy to identify and eliminate, however, as they frequently reverted to Cam^ when 
grown in the absence of selection. Moreover, they did not yield plasmid DNA following 
transformation with pXINT129. Integration by homologous recombination could also be 
avoided by using a recA mutant, such as DHSa, as a host strain. 
The DNA sequences of the plasmids described have been assigned the following 
accession numbers; for pCDl IPKS/SK, AF178449 and AF1784S0; for pCDl IPZl, 
AF178451; and for pCD13PKS/SK, AF178452 and AF178453. 
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Table 2.1: Bacterial strains. 
Kcoli strain Relevant genotype Comments Source or 
reference 
BW19610 uidA::pirll6 Host strain for R6KYorr plasmids Metcalf et al. 
(1994) 
BW19612 uidA::pir* Host strain for RdKyor/ plasmids Metcalf et al. 
(1994) 
DHSa lac, recA Host strain for helper plasmids and Gibco, BRL 
host for plasmid integration at attB 
DH5o^/r pir^  Host strain for R6KYor/ plasmids This study 
DH5apir/J6 pirlJ6 Host strain for YUSYiyori plasmids This study 
MC4100 auB*, tJac Host strain for plasmid integration at CGSC*, 
attB Silhavy et al. 
(1984) 
N3030 gal'76::lTilO Tn/0 linked to attB CGSC 
RPllO a//fi:;pCDl WhcZ MC4100 with pCDl l?lacZ integrated This study 
atiOtB 
TH369 zdg-lil.JnlO TnJO linked to uidA : :pir Thomas Hill 
* K coli Genetics Stock Center 
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Table 2.2: Piasmids constructed in this study for site-specific recombination into the K coli 
chromosome. 
Plasmid Relevant markers Comments 
pCDllPKS/ Cam*, RdKyon, attP  ^
pCDllPSK MCS 
pCD13PKS/ Spc^ RfiKyor/, attP, 
pCD13PSK MCS 
pCDllPterZ Cam*, R6Kyof7, attP, 
lacZ  ^
pCDllPZl Cam*, R6Kyori, attP, 
'lacZ 
pCDllPZla Cam*, R6Kyori, attP, 
'lacZ 
pCDllPZ2 Cam*, KSKyori, attP, 
'lacZ 
pCDllPZS Cam*, R6Kyon, attP, 
'lacZ 
pPICK Kan*, on'"*, cissr, "kint. 
pir* 
pXINT129 Kan*, Xinl, xis 
Plasmid for integration of DNA constructs 
Plasmid for integration of DNA constructs 
Control plasmid for integration of hcT^ 
Plasmid for integration of lacZ gene fusions 
(ORFl) 
Plasmid for integration of lacZ gene fusions 
(ORFl) 
Plasmid for integration of lacZ gene fusions 
(0RF2) 
Plasmid for integration of lacZ gene fusions 
(0RF3) 
Helper plasmid for integration of piasmids 
Helper plasmid for excision of piasmids 
*Temperature sensitive origin of replication 
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Table 2.3 Retrieval of pCDl IP/bcZ by pXINT129-inediated site-specific recombination. 
Number of UkT, Cam*^ colonies retrieved from RPl 10 
transformed with; 
Plasmid DNA isolated 
After growth for: 
pXINT129 No plasmid 
+IPTG -IPTG 
4 hr. >500 187 0 
5hr .  >500 140 0 
6 hr. >500 144 0 
7hr .  >500 95 0 
8 hr. >500 45 0 
Overnight 388 6 0 
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pCDllPKS/^13PKS 
AdteOilM 3  ^BmM Smd m tem teoW nmSm CU Saa mtca na 
pCDllPSK^UPSK 
4mI JOmI £<H MM tel Act JOM CM 
pCDllPKS/SK (3304 bp) 
Cm' 
«P« 
teim 
Figure 2.1: Plasmids for integration of DNA constructs into the K coli chromosome at attB. 
Top, pCDllPKSandpCDllPSK. Bottom, pCDl3PKS and pCD13PSK. Shown are the 
location and orientation of the unique restriction sites within the multiple cloning sites as 
flanked by AssHII sites. 
•imilVTl ^ ^ RM AFM MMTMU PUUILR61 (M ATT OCM OCT OH TILC OS 000 MC CTC TIU MST OO* OCT OCA OOC ATQ CAA OCT TOO 000 ATC OCT OC QIC 
PUIIIMA OA ATT OQA act coo TM; CCO OOO ATC CTC OMI MIT OM ccr OCA OQC ATQ CAA act TOO aao kk axr occ OIC 
puii ircf (MA TIC cMo CTC oor *ex: ooo OQA TCC TCT AOA ore CMC cro CM OCA TOC AM err OOO OOD MC <wr CDC arc 
PUJLINS 0 AAT TOO MC TOO ORA CXC 000 OAT OCT CTA OM TOO OOC TOC AOO CAT OCA >IA; TTO 000 OOO ATC (MT OCC OTC 
pCDllPZl/la/2/3 (TJkbp) 
Figure 2.2 Vectors for construction and integration of lacZ gene fusions into the E, colt 
chromosome. The restriction sites and reading frame of kicZ is shown at the top for 
pCDl IPZl, pCDl IPZla, pCDl 1PZ2, and pCDl 1PZ3. Tl(4) designates four tandem copies 
of the transcriptional terminator from the rniB operon. 
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&»U 
BeaU  ^
PPICX 
(911 ttp) 
km 
r/!/S  ^
pXlNn29 i d^Up) 
MkdDI 
Figure 15i Helper plasmlds for integration and exdsion of integration vectors. Top, pPICK, 
the plasmid for production of A, Int protein, rep designates the gene encoding Rep protein 
from pSClOl. Bottom, pXINT129, the helper plasmid for production of Int and ?Qs proteins. 
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RoKvon' 
attB 
RoKYori 
attL 
B 
attL lacZa RSKyori attR 
B 
Figure 2.4: Integration of suicide vectors by site-specific recombination and confirmation of 
integration by PGR. 
A. Site-specific recombination between attP of an integration vector and attB. The 
integration of the suicide vectors is confirmed by PGR using primers A, B, G, and D that 
hybridize to the locations shown. 
B. PGR confirmation of plasmid integration. Lanes 1-3 show the results of PGR of 
chromosomal DNA fi-om MG4100 where a pGDl IP-derivative plasmid had been 
integrated at attB. Lanes 4-6 are fi'om MC4I00. The primer pairs are; lanes 1 and 5, 
A+B (O.S kb product); lanes 2 and 6, A-iC (0.6 kb product); lanes 3 and 7, B+D (l.l kb 
product). Lane 4 shows a 1 kb ladder as a molecular weight standard. 
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CHAPTER 3. REVERSIBLE INTEGRATION 
OF DNA CONSTRUCTS INTO THE CHROMOSOMES OF 
ESCHERICHIA COU XNO SALMONELLA TYPHIMURIUM 
BY A BACTERIOPHAGE P22-MEDIATED 
SITE-SPECIFIC RECOMBINATION SYSTEM 
A paper to be submitted to the Journal of Bacteriology 
Ratree Piatt and Gregory Phillips 
ABSTRACT 
A genetic system has been developed that utilizes the site-specific recombination 
(SSR) components of bacteriophage P22 to integrate DNA constructs into the Salmonella 
typhimurium and Escherichia coli chromosomes. Chromosomal integration by SSR 
overcomes problems associated with the overexpression of genes on a multicopy plasmid that 
may be detrimental to cell growth and can provide a more accurate measurement of gene 
expression as monitored by a reporter gene. Integration at ataA or attP22 sites also insures 
that no functional host gene is inactivated upon insertion. The system includes a 
conditionally replicating plasmid that carries the R6KY origin of replication, bacteriophage 
P22 attachment site, multiple cloning sites, and imparts resistance to kanamycin, 
chloramphenicol, or spectinomycin. SSR is accomplished using a helper plasmid that 
expresses the P22 int gene and replicates using a temperature sensitive origin of replication. 
The recombinant formed as a result of P22 SSR was characterized by sequencing. Recovery 
of the integrated constructs can also be achieved using a second helper plasmid that carries 
both the P22 xis and int genes. This system was demonstrated to be efficient in both 
integration and excision of plasmid vector DNA in both K coli and S. typhimurium. The 
successful integration and expression of lacZ in S. typhitnurium by P22 SSR was also 
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demonstrated. In combination with previously constructed X SSR systems (Piatt, R., 
Drescher, C., Park, S-K., and Phillips, G.J. 2000. Genetic system for reversible integration of 
DNA constructs and UkZ gene fusions into the Escherichia coli chromosome. Plasmid. 
43:12-23), the P22 system permits integration of gene constructs at two chromosomal 
locations. 
INTRODUCTION 
Site-specific recombination (SSR) is a strategy used by a variety of bacteriophages, 
including X and P22 to lysogenize their host by reversibly integrating their genomic DNA 
into their host's chromosome. SSR characteristically occurs between specific DNA 
sequences, so called att sites. Integration of phage DNA does not require homologous 
recombination and occurs by a reciprocal, conservative recombination event (Nash, 1996). 
The SSR machinery of bacteriophage X has been exploited for the development of a number 
of systems to integrate genes into the chromosome of Escherichia coli (Simons et ai, 1987; 
Atlung et al., 1991; Diederich et ai, 1992; Hasan et al, 1994; Yu and Court, 1998; Lee et al.^  
1999, Piatt et ai, 2000). These systems are convenient to characterize the function and 
regulation of a gene in single copy. This feature is especially important when employing a 
reporter gene such as UkZ to monitor gene expression since resuhs can be misinterpreted as 
plasmid copy number can change with different growth conditions or genetic background of 
the bacterial strain. Experimental results can also be influenced by unnaturally high levels of 
a regulatory protein or c»-acting regulatory sequences present on high copy number 
plasmids. Stable integration of DNA constructs also obviates the need for continual 
antibiotic selection for their maintenance. Moreover, since integration occurs at the specific 
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X phage attachment site (attB) no functional host gene is inactivated. A system previously 
reported by Piatt etal. (2000) utilizes conditionally replicating plasmids as vectors for 
integration and making it feasible to easily retrieve the entire integrated plasmid. 
To extend the utility of SSR for construction of new strains of Salmonella 
typhimurium and E. coli, an integration system based on P22, a lysogenic phage of S. 
typhimurium (Zinder and Lederburg, 1952) was developed. By analogy with bacteriophage 
X, a specific attachment site for P22 {alaA) has been mapped on the S. typhimurium 
chromosome at minute 7 nsasproBA (Sanderson and Roth, 1983). Interestingly, although 
coli is not susceptible to P22 infection, it also contains an attachment site for P22 on its 
chromosome (Lindsey et ai, 1992). The attP22 site also maps near proBA, overlapping with 
thrW, at minute 6. Conveniently, this makes the SSR system amenable for Kcoli as well as 
Salmonella. Also, in a manner analogous with bacteriophage X, P22 uses the Int protein to 
promote integration of the P22 DNA (Lindsey et a/., 1992) while excision of the phage 
requires both Int and Xis proteins (Leong et al., 198S). 
In this study, we report the construction of a P22-mediated SSR system that utilizes 
the SSR machinery of P22 in combination with conditionally replicating plasmid vectors 
using the R6KY origin of replication (on). The R6KY on plasmid replicates only in the 
presence of the IT protein encoded by the pir gene (Kolter et ai, 1978). In the absence of IT, 
the R6KY on plasmid functions as a suicide vector and must integrate into its host's 
chromosome in order to obtain stable, antibiotic resistant recombinants. The plasmid vectors 
developed in this study contain the attachment site from P22 phage (P22a/lP), multiple 
cloning site (MCS) to facilitate insertion of DNA constructs to be integrated into the bacterial 
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chromosome, and either a kanamycin resistant (Km*^), chloramphenicol resistant (Cm*^), or 
spectinomycin resistant (Sp*^) marker. Two "helper" plasmids provide the Int and Int/Xis 
functions of P22 phage to promote integration and excision of the suicide vectors. These 
vectors are transiently maintained in the cells by use of a temperature sensitive (TS) origin of 
replication from pSClOl. This system was effectively used for strain construction in both £. 
coli and S. typhimurium. The integration and expression of lacZ gene in S. typhimurium by 
P22 SSR was demonstrated. In addition, multiple gene insertions in E. coli at both the X, and 
P22 attachment sites is possible when the X and P22-mediated SSR systems are used in 
combination. These vectors should have broad application for the construction of E. coli and 
S. typhimurium to analyze gene function. Application of this system for the production of 
live vaccine strains expressing various antigens of interest is also discussed. 
MATERIALS AND METHODS 
Strains and plasmids. The bacterial strains, bacteriophages, and plasmids used in 
this study are listed in Tables 1 and 2. The maps of relevant plasmids are shown in Fig. 1. 
Media and diemicals. Luria-Bertani (LB) medium (Sambrook etcU., 1989) was 
used to grow all cultures. The concentrations of antibiotics were as follows: Ampicillin (Ap) 
100 ^g/ml. Cm 20 ^g/ml, Km 30 |ig/ml, Sp SO ^g/ml, and tetracycline (Tc) 20 ^g/ml. 
Bacterial cultures were grown at ZTC unless otherwise indicated. The Lac phenotypes of the 
bacteria were demonstrated on agar plates spread with 100^1 of 1% X-gal (S-bromo-4-
chloro-3-indoyl-P-D-galactopyranoside). 
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Techniques of recombinant DNA and bacterial genetics. Standard techniques of 
recombinant DNA (Sambrook et ai, 1989) were performed. Enzymes, reagents, 
bacteriophage DNA and bacterial genomic DNA preparation kits were obtained from 
commercial sources and used according to the manufacturers' reconmiendations. 
Transformations were performed either by electroporation (Sheng et al., 1995) or chemical 
transformation (Inoue et al., 1990). Isolation of plasmid DNA was by a modified protocol 
reported by Carter and Milton (1993). Transductions with bacteriophages PI and P22 were 
performed as described by Miller (1992) and Maloy (1990), respectively. The DNA 
sequencing was performed by the DNA sequencing and synthesis facility, Iowa State 
University. 
Polymerase chain reaction (PGR). All PCRs were performed in a total volume of 
SO ^1 in a Perkin Elmer Gene Amp PCR System 2400 (Perkin-Elmer, Foster City, CA) 
thermocycler using 25 cycle of 94''C, 50*'C, and 72*'C, at 30 seconds each with a 2 minute 
hold at the end of the last cycle, unless otherwise indicated. The PCR products were 
visualized after gel electrophoresis and ethidium bromide staining. 
Plasmid constructions. 
Integrated plasmid vectors. Plasmid vectors for integration include the Km*^ 
plasmids pCD21PKS/SK, Cm*^ plasmids pCD22PKS/SK, and Sp*^ plasmids pCD23PKS/SK. 
pCD22PKS was derived from pCDl IPKS by replacing X attP with attP from 
bacteriophage P22. Two PCR primers (5*CCCATACACACAAAAAGCAAATACG3' and 
5'TTCAATCTCCGCTGCATACTGTCCAGG3') were designed to amplify the P22 int gene 
63 
and the adjacent attP site from purified P22 DNA. The PGR product was digested with J6nn 
/and inserted into pNoTA. The resulting plasmid was digested withBaniR I and inserted 
adjacent to ca/ in a derivative of pKRPlO at a Bel I site. A cat-attP22 cassette was liberated 
with BspYl I digestion and was ligated with I-digested pCDl IPKS. The ligated 
product was transformed into lXi5aPirll6 and selected for Cm*^. 
To construct pCD22PSK, pCD22PKS and pCDl IPSK were both digested with Nhe I 
and Bgl I. The 2.5 kb fragment of pCD22PKS was ligated with the 1.0 kb fragment of 
pCDl IPSK to obtain pCD22PSK. The 1.3 kb Stu I fragment containing Km resistant 
cassette from pBGS8 was ligated to the 2.6 kb Ssp I fragments of pCD22PKS/SK to generate 
pCD21PKS/SK. Similarly, the 2.0 kb Dra I fragment containing spectinomycin resistant 
gene cassette from pKRP13 was ligated with the 2.6 kb Ssp I fragments of pCD22PKS/SK to 
generate pCD23PKS/SK. ^D22?lacZ was constructed by digesting pCClacZS carrying 
UkZ with EcoK I and the 3.5 kb lacZ fragment was ligated with pCD22PKS digested with 
the same enzyme. All R6KY ori plasmids were transformed into DH5a/'ir//tf and selected 
by appropriate antibiotic. 
Helper plasmids. To construct the plasmid pXINT-A22 which serves as the 
helper plasmid for excision. Two PGR primers 
(5'ATGGATGCAGCGGAGTAAAGATGGAATGAG3' and 
5'AAGGATCGTTAGGTATTATTGGTGGGTTCG3') were used to amplify a 1.6 kb 
fragment contains xis and int from purified P22 DNA. These primers were also synthesized 
with BamH I restriction site at the 5* ends. The PGR product was digested with BamK I and 
was ligated to dephosphotylated BamH I digested pUG18 creating pXINT-A22. pXINT-K22 
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was constructed by ligating a BaniR I fragment carrying P22 xis and int from pXINT-A22 
with BomH I digested pWSKl29. 
The pUClS-derivative ori helper plasmid used for plasmid integration, pINT-P22, 
was derived by self-Iigation of pXINT-A22 digested with EcoK V and Ecl\26 n. The TS ori 
helper plasmid, pINT-A22, was constructed by the ligation of an £coR I and Sea I fragment 
encoding the P22 int gene from pINT-P22 and a 4 kb fragment of pTSA30 digested with the 
same enzymes. pINT-K22 was constructed by the ligation of an £coRV and Hinc II 
fragment of pXINT-K22 and £coRV digested pTSK29 with TS ori. 
An additional helper plasmid for integration, pAPRIL, was also constructed to 
facilitate the integration of plasmids using both the X and P22 SSR systems. pAPRlL was 
obtained by ligation of a Apa VPvu I fragment from pYWHlOl carrying "K int gene and 
pTSA30. 
pPiri030. This plasmid contained apir gene that expressed a n protein to 
support the replication of R6KY or/ plasmid in the host without the pir gene. The plasmid 
was constructed by inserting a 1.0 kb EcoK I fragment from pTA-p/r (Phillips, G. J. 
unpublished) into the low copy number cloning vector derived from pRSF1030 (Phillips, G. 
J. unpublished) at EcoK I. 
bolation of a plasmid cointcgnmt Two PGR primers were designed to amplify the 
attP22 sequence from the K coli chromosome (primer A: 
5'CGGCACACAACACTCCGAT3' and primer B: 
S'GGCAAGGATGTATAGTGAGCGAA3'). The S61 bp PGR product was ligated with the 
plasmid pT-Adv, transformed into competent Top 10 cells and Km^ and Ap*^ transformants 
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were selected on an X-gal containing plate. pT-aitP22 was confirmed by restriction enzyme 
analysis and cotransformed into DHSa carrying pINT-P22 with selection for Km*^ and Ap^ 
Finally, pCD22PKS was transformed into DHSa carrying 2 plasmids, pT-attP22 and pENT-
P22, Cam*^ transformants were selected and subsequently screened for Km*^ and Ap*^. The 
7.7 kb cointegrant plasmid between pCD22PSK and pT-attP22 was digested with Ssp I and 
Pme I and self-ligated to eliminate a copy of lacZa from pCD22PKS which would interfere 
with the DNA sequencing using primers internal to lacZa. The resulting 5.4 kb plasmid, 
pTAP22 (Km*^ and Ap*^), was used to determine the sequences of the attL and attR regions. 
Chromosomal integration of pCD2-P- derivative plasmids into K coii pINT-A22 
was transformed into MC4100. Ap*^ transformants were selected at 30°C. pCD22PKSwas 
then introduced into the transformant by selection for Cm*^ at 30''C. The colonies were 
restreaked twice on LB + Cm at 42''C to eliminate the helper plasmid. Ampicillin sensitive 
(Ap^) colonies were identified and the presence of the integrated plasmid was confirmed by 
PCR. 
Chromosomal integration of pCD2-P- derivative plasmids in Sityphimurium, 
Due to the difference in the restriction-modification (R-M) system between E. coli and 
Salmonella  ^all plasmids originated from E. coli that was used for P22 SSR in Salmonella 
were modified to survive the Salmonella restriction system. The S. typhimurium mutant, 
LBSOlO ifm*) (BuIIas and Ryu, 1983) was used for this plasmid modification purpose. 
LBSOlO with pPirl030 was used to modify the R6Ky on-derivative plasmids. The S. 
tyl^imurium modified plasmids were isolated from these strains and used for chromosomal 
integration in S. typhimurium. pCD22PlacZ was integrated and the Lac phenotype was 
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demonstrated by streaking on a LB + Cm + X-gal plate. The integrant was cultured in LB 
broth for 10 passages with no selection before plating on the X-gal containing plate to 
observe integration stability. 
Characterization of plasmid integration by transduction. To determine if the 
plasmid vectors pCD2-P- had integrated at multiple sites on E. coli and S. typhimurium 
chromosomes, genetic tests using bacteriophages PI and P22 transductions were performed. 
We reasoned that transducing an a//P22;:pCD22PKS K coli host with a PI lysate prepared 
from a i»'o-81::lnl0 donor should result in loss of Cm*^ at a frequency representing the tight 
linkage betweenpro-^ y.-.Tn/O and attP22. Similarly, transducing an a/a4;;pCD22PKS S. 
typhimurium host with a high transduction (HT) P22 lysate prepared from a proBI657::TnlO 
donor should resuh in loss of Cm*^ at a frequency representing the tight linkage between 
proBJ657::TnJ0 and ataA. 
In K coli, SO independently-isolated integrants of pCD22PKS in MC4I00 were used 
as recipients for bacteriophage PI transduction (Miller, 1992) using a PI vir lysate grown on 
CAG18447. In S. typhimurium, SO independently-isolated integrants of pCD22PKS in S. 
typhimurium were used as recipients for bacteriophage P22 transduction (Maloy, 1990) using 
a P22 high transducing (HT) phage grown on JL2S20. The transductants were selected and 
subsequently patched on LB + Tc plates. The patches were scored for Cm^ by replica 
plating. 
PGR assay for plasmid integration in E coti. The integration of a plasmid vector 
at attP22 was also confirmed by PGR by a similar approach as the attB integration reported 
by Piatt etcd. (2000). In £ co//, the same PCR primer pair (primer A and B) employed to 
67 
amplify the intact attP22 site was used. Two additional primers were designed to anneal to 
sequences within the pCD2-P- derivatives (primer C: 5'GGTTCGCCGATATGCTCATC3' 
and primer D: 5'CAGCGGATTCGGAAAGGTCTG3*). If the pCD2-P- derivatives had 
correctly integrated into the K coli chromosome at attP22 site, primers A and C produced a 
SS1 bp attL product and primers B and D produced a 479 bp attR product. 
PCR assay for plasmid integration in S. typhimurium. A primer pair, primer E: 
5'ACTCATGGCGCATGGTAAACAAGA3' and primer F: 
5*ATGAGGTTGTACATAAGTGA3'(Cho etal. 1999), was designed from chromosomal 
sequence to amplify a 348 bp fragment represent the intact ataA site of S. typhimurium. In 
the integrant, primer E pairs with primer D were used to amplify a 470 bp attR product while 
primers F and primer C were used to amplify 346 bp attL product. 
Retrieval of integrated plasmids. The helper plasmid for excision, either pXINT-
A22 or pXINT-K22, was transformed into an E. coli integrant of pCD22PKS and plated on 
LB + Ap + Cm or LB + Km + Cm plates, respectively. For the S. t)phimurium integrant, the 
helper plasmids for excision were initially transformed into LBSOlO before being introduced 
into K coli. Six individual transformants were separately inoculated into 6 LB Ap or LB + 
Km broth cultures. Each tube was collected for plasmid extraction at 4 hours after incubation 
and repeated at S, 6,7,8 hours and following overnight incubation. The plasmid DNA 
preparations from both K coli and S. typhimurium were used to transform DHSo^ir//5 and 
selected for Cm^ The retrieved pCD22PKS was compared to the original plasmids by 
restriction enzyme analysis. 
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Integration of plasmids at two chromosomal locations in £ coii. The helper 
plasmid for integration by X SSR, pAPRIL, was transformed into an E. coli strain when 
pCD22PKS had been integrated into attB. Ap*^ colonies were selected at SO^C. pCDl3PKS 
was transformed into the TS transformants, selected for Sp*^ at 30*'C and restreaked twice at 
42''C. The integration of pCDUFKS at attB was confirmed by PCR (Piatt et al.2000). 
Integration of plasmids at two chromosomal locations in S.typhimurium. The 
helper plasmid for integration by \ SSR, pAPRIL, was transformed into S.typhiniurium strain 
LBSOlO and selected for Ap*^ at SO^C. pCDl IPKS was transformed into the TS 
transformants, selected for Cm*^ at BCC and restreaked twice at ATC to eliminate pAPRIL. 
The transformant was then transformed with pINT-A22 and selected for Ap*^ at SCC. The 
pINT-A22 transformant was transformed with pCD21PSK with selection for Km*^. The 
pCD21PSK integration at ataA was confirmed by PCR. 
Retrieval of integrated plasmids from an £ coli integrant of both SSR systems. 
pXINT-A22 was transformed into an E. coli integrant of both pCD13PKS and pCD22PKS 
(described previously) and plated on LB + Ap + Cm plates. The transformants were cultured 
in LB + Ap broth for 4 hours and the plasmids were extracted and transformed into 
DliScipirJJ6. Likewise, pXINT129 was also transformed into the same E. coii integrant and 
plated on LB + Km + Sp plate. The transformants were cultured in LB + Km broth for 4 
hours and the plasmids were extracted and transformed into DHSapirllS. The transformants 
were plated on LB + Cm plate to detect the presence of pCD22PKS and LB + Sp plate to 
detect the excision of pCDlSPSK. 
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RESULTS 
Plasmid integration in £ coli and SLtyphimurium. We constructed a series of 
plasmid vectors, including pCD21PKS/SK, pCD22PKS/SK, and pCD23PKS/SK, designed to 
facilitate the integration of plasmid DNA into either the E. coli or S. typhimurium 
chromosome. To test these vectors we co-transformed both E. coli and S. typhimurium with 
one of the pCD- plasmids, along with the helper plasmid expressing P22 Int and integrated 
the suicide vector into the bacterial chromosome, as described in Materials and Methods. 
The Cvc^l Km^ recombinants were screened for the presence of the pCD2-P- vector by 
generalized transduction and PCR. 
Characterization of integrated DNA by transductions. If the pCD2-P- vectors had 
integrated into ataA of S.typhimurium or attP22 of K coli, we predicted that they should be 
tightly linked to genes adjacent to these sites on the chromosomes. As described in Materials 
and Methods, we transduced E. coli with PI phage lysate prepared from aproSl vUnlO 
donor and S. typhimurium integrants with P22 phage lysate prepared from a proBJ657::TnJ0 
donor respectively. All SO PI transductants of E. coli and P22 transductants of S. 
typhimurium integrants, when screened for chloramphenicol resistance, showed either all 
Cm^ or mixed Cm^ and Cm*^ phenotypes. These results confirmed the tight linkages between 
pro-81:-^ nl0 and attP22 in E. coli and between proB1657\ JlnlO and ataA in S. 
typhimurium. This experiment also confirmed that all of the integrants represented inserted 
pCD2-P- at a single locus since the acquired Tc*^ from TnlO was almost parallel to the lost of 
Cm*^ which indicated the replacement of the Cm*^ gene by the Tc*^ gene at the same location. 
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If the plasmid integrated into the host chromosome at mukipie loci, the Cm*^ phenotype 
should remain in all Tc*^ transductants. 
Confirmation of plasmid integration by PCR. A PCR assay was used as a second 
approach to confirm that the pCD2-P- plasmid had recombined into ataA or aitP22 as shown 
in Fig. 3.3. PCR primers A and B were used to amplify a 561 bp product representing the 
intact attP22 site firom E. coli in combination with other two primers (C and D) specific to 
the plasmid vector. In the K coli pCD2-PKS/SK derivative integrants, primers A and C 
amplified a 551 bp attL product, and primers B and D amplified a 479 bp attR product. A 
similar result was observed with the S. typhimurium integrants by the generation of a 470 bp 
attR product by the PCR primers D and E and a 346 bp attL product by primers C and F (Fig. 
3.3). 
Study of the integration pattern of P22 SSR in E coti by DNA sequencing. We 
also took advantage of this plasmid-based system to characterize the products of the P22 SSR 
reaction. To accomplish this, a cointegrant plasmid, pTAP22, was constructed as described 
in Materials and Methods. This plasmid was generated by integrating pCD22PKS into a 
pBR322-derivative plasmid carrying E. coli attP22. Its configuration was confirmed by 
restriction digestion as well as by DNA sequence analysis. Although the P22 attL and attR 
sites contain an identical 46 bp common core sequence; they can be differentiated by the 
DNA sequence of the surrounding DNA. The sequencing resuhs showed that the attL and 
attR sites, contained one arm from the E coli and the other from the P22 phage DNA. The 
same 46 bp common core oiattL and attR of£l coli integrant was identical to the common 
core of the attP22 of the £. coli chromosome and P22 attP of phage DNA (Fig.3.4). The 
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orientation of plasmid integration was identical in all integrants, consistent with the resuhs of 
the PCR reactions. 
Expression of heterologous protein in & typhimuriunu To test the SSR system for 
expression of genes in S. typhimurium, a derivative of pCD22PKS was constructed that 
carried the E. coli lacZ gene. The resuking plasmid, pCD22P/acZ, was integrated into S. 
typhimurium chromosome. The integrant stably expressed 3-galactosidase when plated on 
X-gal containing LB plates without antibiotic selection. This confirmed that S. typhimurium 
can express heterologous protein integrated by site-specific recombination. 
Plasmid excision and recovery. The vector system described here also permits 
recovery of the integrated plasmids. The excision process mimics the SSR reaction that P22 
utilizes to excise its DNA out of the host chromosome. The process requires both the Int and 
Xis proteins to recognize the atiL and attR sites for recombination. To recover the integrated 
plasmids we introduced either pXINT-A22 or pXINT-K22 into Kcoli and S. typhimurium 
integrated with pCD22PKS. The helper plasmids, pXINT-A22 or pXINT-K22, expressed 
both Int and Xis and promoted excision of pCD22PKS out of both the E. coli and S. 
typhimurium chromosomes. pCD22PKS was retrieved after growth in DHSo^/r//tf 
encoding 11 protein required for R6KY ori plasmid replication (Piatt et al.^ 2000), in the 
presence of chloramphenicol. Characterization of retrieved plasmid by restriction enzyme 
analysis showed the same fragment sizes from several restriction enzymes as the original 
plasmid (data not shown). This confirmed the complete cycle of the whole plasmid vector 
integration and excision by P22 SSR 
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Integration of plasmids at two chromosomal locations in £ coH. A number of 
bacterial strain constructions may require introduction of DNA constructs to two different 
locations of the bacterial chromosome. We tested if the P22 SSR system could be used in 
combination with a previously described system using X SSR (Piatt et al., 2000). When the 
E. coli integrant of pCD22PKS, integrated at atiP22 site, was u-ansformed with pCDUPSK 
carrying different antibiotic resistant gene, pCD13PSK was successfully integrated at the 
attB site in the presence of X Int protein provided by a helper plasmid for integration. 
Integration of plasmids at two chromosomal locations in S. typkimurium. Even 
though S. typhimurium does not contain primary attachment site for bacteriophage X, 
pCDl IPKS plasmid integrated into S. typhimurium chromosome. The integration of the 
second R6KY ori plasmid (pCD21PKS) with 3 kb homologous sequence at ataA site is 
possible in the presence of P22 Int provided by helper plasmid for integration. The plasmid 
integration at ataA site was confirmed by PGR. 
DISCUSSION 
The successful development of a plasmid-based integration system utilizing the X 
SSR machinery by our laboratory (Piatt et ai, 2000) prompted us to construct a similar 
bacteriophage P22-mediated integration system to expand the tools available for bacterial 
strain construction. The opportunity to stably express foreign antigens in S. typhimurium was 
also a motivation for developing a plasmid-based P22 SSR system. This system is an 
effective tool to integrate a gene of interest into the P22 attachment sites on the chromosomes 
ofE. coli (attP22) and S. typhimurium {ataA). The recombinants were shown to represent 
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integration of the pCD2-P- vectors at the specific attachment site of bacteriophage P22 and 
were stably maintained without continual antibiotic selection. The application of the P22 
SSR system described here is similar to the X SSR system in K coli (Piatt et al.^ 2000). This 
system also permits integration of different genes into both E. coli and S. typhimurium 
chromosomes at 2 specific locations when applied consecutively with the X SSR system. 
Although there was DNA homology between the two R6KY ori plasmids the integration of 
the second plasmid was at attP22 and ataA sites respectively as confirmed by PCR of each 
host. Depending on the amount of homology, the homologous recombination is 10^- to 10^-
fold less efficient than the X SSR system (Silhavy et al., 1984). 
Moreover, plasmid integration at the known attachment sites ensures that no essential 
host gene function is interrupted. Lindsey et al. (1992) reported the overlapping sequences 
of the 46 base common core sequence of attP22 and the 3' end of thrlV gene. The 
integration of P22 phage into E. coli chromosome replaced the host sequence at the 3' end 
with the exactly same sequence from the P22 phage DNA (Lindsey et al., 1992). A similar 
integration pattern was also demonstrated in bacteriophage P4 (Pierson m and Kahn 1987). 
In this system, the replacement of the attP sequence of the P4 phage at the 3' end of tRNA 
leuX gene in E. coli did not interrupt the expression and function of the tRNA despite the 
presence of the cryptic integrase sequences at the 3' end of the transcript. 
Our previous report (Piatt et al., 2000) confirmed that the plasmid vector of the X. 
SSR system was integrated at the primary attB site with no evidence of multiple site 
integration. However, integration of the plasmid at a secondary attB site was detected in the 
host with primary attB site deletion (unpublished data). In this study, transduction 
experiments of both £. coli and S. typhimurium integrants confirmed that all integrants had 
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single site pCD2-P- integration. Although not tested, it is likely that second attP22 sites also 
exist on the E. coli and S. typhimurium chromosomes. The wide variety of antibiotic 
resistance in the plasmid vectors and helper plasmids expands the application of the P22 SSR 
system in a host that may contain other existing antibiotic resistance. 
The plasmid pTAP22, derived from a cointegrant of pCD22PKS and pT-attP22 (a 
plasmid carrying K coli attP22), was constructed to use as a sequencing template for P22 
attL and attR. The DNA sequences showed the expected recombination product of P22 SSR 
at both attL and attR sites on K coli. The 46 bp common core is identical in both the K coli 
and S. typhimurium P22 attachment sites. Our resuhs showed that the left arm of the attL and 
the right arm of the attR sequences were derived from the E. coli chromosome while the left 
arm of the attR and the right arm of the attL sequences were from the P22 phage DNA 
carried by pCD22PKS (Figure 3.4). The data also corresponded to the results of the PGR 
assay used to characterize the pattern of integration of pCD22P- on the E. coli and S. 
typhimurium. These resuhs are consistent with the P22 phage lysogenization in Salmonella 
reported by Leong et ai (198S) identified by restriction enzyme analysis. This group, 
however, did not report the DNA sequencing data. 
The X Xis protein inhibits integrative recombination and is required for excisive 
recombination (Abremski and Gottesman, 1982, Bushman et al., 1984, Moitoso and Landy, 
1991). The role of Xis is to provide a distinct reactive structure at attR and allow an efficient 
paring between attL and attR (Better et aL, 1983). The regions of Xis binding present in both 
the attP and attR (Yin et al., 1985). These reports confirmed the high specificity of Xis 
protein to initiate X excisive recombination. 
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One specific application of the P22 SSR system for stable gene integration in 
bacterial chromosome is a promising model for future recombinant E. coli and Salmonella 
vector vaccines expressing foreign antigens. For example, normal flora E. coli that naturally 
resides in the digestive tract may serve as a host for expression of heterologous antigen. The 
establishment of a normal flora E. coli host in the gut will continually provide a supply of the 
foreign antigen. If it is needed, conditional expression of the gene product can be achieved 
using a different regulatory system rather than the constitutive Lac expression system used in 
pCD2-P- derivative plasmids. The conditional expression of the foreign gene may be 
advantageous to prevent the destruction of the live bacterial vaccine by specific host defense 
mechanisms and will avoid host tolerance due to continuous exposure to the foreign antigen 
(Kuby, 1994). The ability to stably integrate DNA constructs at two chromosomal locations 
in E. coli expands further applicability of the system to express more than one foreign gene at 
a time. 
Even though the primary attachment site of bacteriophage \ was not mapped on the S. 
typhimurium chromosome, Lee, et al. (2000) successfully utilized the \ SSR system to 
integrate enterotoxigenic E. coli K88 gene cluster into the chromosome of S. choleraesuis 
strain 54 (SC54) to use as a vaccine candidate in animals. The expression of the K88 antigen 
was also demonstrated in this study. Although the integration site was not identified, 
maintenance of the integrated plasmid did not require antibiotic selection. 
Attenuated S. typhimurium has been successfully used to express heterologous 
antigens or fusion proteins of either bacterial, viral, or protozoan origin or other novel 
antigens, e.g., cytokines and contraceptive antigens 9)oggett and Brown, 1996). Salmonella 
tends to withstand macrophage killing and confers the advantage of being an expressing 
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vector with respect to survival in the host (Ramsey et ai., 1994). Expression of the 
heterologous antigens in Salmonella has been shown to induce both humoral, especially 
mucosal immune responses, and cell-mediated inmiune responses to purified recombinant 
antigens (Doggett and Brown, 1996). One problem encountered with the expression of 
antigens by recombinant plasmids is the instability of the plasmids in the absence of 
continual selection. To stabilize the antigen expression, integration of the gene into a 
Salmonella chromosome has been practiced mainly by homologous recombination (Chatfield 
etal., 1992; Cardenas and Clements, 1993) or a balanced-lethal host-vector system 
(Nakayama et al.y 1988). The recombinant plasmid, pCD22VlacZ, constructed In this study 
demonstrated that stable expression of a heterologous gene integrated in S. typhimurium 
chromosome by P22 SSR could be achieved. 
In addition to facilitating strain construction, the described vector system can also be 
used for analysis of gene function. For example, a gene can be cloned into the R6KY ori 
plasmid vector and integrated into a host chromosome. A mutagenesis of the inserted gene 
can be performed and screened for a specific mutant. The mutated gene can be easily 
excised out of the host chromosome as described and recovered by transformation into the 
host strain D}^S<jpirU6 (Piatt et ai, 2000). The recovered plasmid can then be used directly 
for DNA sequencing or further genetic manipulation. 
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Table 3.1 Bacterial strains and bacteriophages used in this study 
Strain Relevant genotype Conunent Source/ Reference 
E. coli DH5a recA, r-m+ Host for plasmid replication Gibco-BRL, 
NY 
DH5a/>ir//5 recA, r-m+, pirI16 Host for R6Ky ori plasmid Piatt eM/., 
replication 2000 
MC4100 r+m+ Host for homologous CGSC 
recombination 
MG1655 recA Host for plasmid integration Miller, 1992 
CAG18447 pro-8I::TnlO Donor host for PI transduction CGSC, 
Singer a/.. 
1989 
S. typhimurium Wild type Host Tor plasmid integration NADC 
JL2520 proBl657::TnlO Donor host for P22 transduction SGSC. 
Sanderson and 
Roth, 1983 
LB5010 r-m+ Host for plasmid modification Bullas and Ryu, 
from £ coli system to 1983 
S. typhimurium. 
P22 wild type Source of attP22 site, xis, and int Miller, 1992 
genes 
HT Transducing phage Maloy, 1990 
PI vir Transducing phage Miller, 1992 
CGSC; E. colt Genetic Stock Center 
SGSC; Salmonella Genetic Stock Center 
NADC; National Animal Disease Center 
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Table 3.2 Plasmids used in this study and their relevant genotypes 
Plasmid ori Relevant genotype Ab^ Comment Source or reference 
pUClS ColE\ iacZa, MCS Ap cloning vector. Pharmacia. 
Piscataway, NJ. 
pNoTA Co/El iacZa, MCS Ap cloning vector 5 -^ y Inc. 
Boulder, CA. 
pT-Adv Co/El lacZa, MCS Km, cloning vector for PCR product CloneTech. 
Ap Palo Alto, CA. 
pBGSS Co/El lacZa, MCS Km cloning vector Spratt. etal., 1986 
pWSK129 pSCIOl lacZa, MCS Km cloning vector. PhUUps, 1999. 
pTSA30 fSCIOl^ lacZa, MCS Ap temperature sensitive cloning vector. PhflUps, 1999 
pTSK30 pSCIOl^ lacZa, MCS Km temperature sensitive cloning vector. PhilUps,1999 
pYWHlOl pSClOl /tint, lad Ap Source of A INT Hane/a/., 1994 
pCClacZS Co/El UkZ Ap Source of lacZ gene. Miller 1992 
pKRPlO Co/El cat Cm Source of chloramphenicol resistant Reece and Phillips, 
Kit^ 
cassette gene. 1995 
pKRPll Co/El Km, Source of kanamycin resistant Reece and Phillips, 
V 
Ap cassette gene. 1995 
pKRP13 ColEl Sp, Source of spectinomycin resistant Reece and Phillips, 
Ap cassette gene. 1995 
pCDllPKS^K R6KY IacZa, MCS, XaltP Cm plasmid vector for integration at 
otiB» 
Plan era/., 2000 
pCDl3PKS/SK R6Ky lacZa, MCS, XattP Sp plasmid vector for integration at 
ottB* 
Platte/a/., 2000 
pCD21PKS«K R6Ky IacZa, MCS, P22 Km plasmid vector for integration at This study 
attP attP22 or ataA. 
pCD22PKS/SK R6KY IacZa, MCS, P22 Cm plasmid vector for integration at This study 
attP attP22 Of ataA. 
pCD23PKS/SK R6Ky IacZa, MCS, P22 Sp plasmid vector for integration at This study 
atiP attP22 or ataA. 
pCD22PfacZ R6KY lacZ P22 attP Cm plasmid for integration of lacZ gene This study 
dXatlP22atataA. 
pPirlOBO Co/El pir Ap provide x protein for R6KY ori This study 
pSCIOI^ 
plasmid replication. 
pPICK Aim, pir Km helper plasmid for integration at Piatt e/o/., 2000 
pSClOl^ 
a/tS with/»> gene. 
pAPRIL /Lint Ap helper plasmid for integration at This study 
aliB without pir gene. 
pINT-P22 ColEl intP22 Ap helper plasmid for integration at This study 
attP22 at ataA. 
pINT-A22 pSClOl^ intP22 Ap helper plasmid for integration at This study 
aitP22 or ataA. 
pINT-K22 pSCIOl^ intP22 Km helper plasmid for integration at This study 
attP22 at ataA. 
pXINT-A22 ColEl xisP22, intP22 Ap helper plasmid for excision fh>m This study 
attP22 or ataA. 
PXINT-IC22 ColEl xisP22, intP22 Km helper plasmid for excision fiom This study 
attP22 or alaA. 
pT-altP22 ColEl altP22 Cm, intermediate cointegrant plasmid for This study 
Km, 
An 
sequencing orP22 attL ami aoR. 
pTAP22 ColEl atlP22:: 
P 
Km, cointegrant plasmid for sequencing This study 
vCDTlPKS&lacZa Ap of P22 atlL and attR. 
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Kjm\ Apal Xho\ Sail Hind\\\ EcoRV EcoRl PsA Smal BamW Spel Xbal Noll &K;II Sacl 
Sacl S^TT Noil Xbal Spel BomHT Sinai Psfl EcoRl £coRV //mdITT SaR Xhol Apal Kpnl 
ReKvon 
pCD21PKS/SK 
(4.0 kb) Xbal 
attP22 
pCD22PKS/SK Cm'^ (3.5 kb) 
pCD23PKS/SK Sp'^(4.8kb) 
Figure 3.1 Plasmid vectors for integration.. 
The pCD2-PKS/SK contain the R6KY on', attP from bacteriophage P22, antibiotic 
resistant cassette and the multiple cloning site within the lacZa coding region. The antibiotic 
resistant cassette in pCD21PKS/SK, pCD22PKS/SK, and pCD23PKS/SK are kanamycin, 
chloramphenicol, and spectinomycin respectively. 
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int 
int 
lean 
rep 
Figure 3.2 Helper plasmids for integration and excision. 
The helper plasmid for integration, pINT-A22 / pINT-K22, carries int gene, 
ampicillin/kanamycin resistant cassette and /i5C101^ on*. 
The helper plasmid for excision, pXINT-A22 / pXINT-K22, carries both the xis and 
int genes, ampicillin/kanamycin resistant cassette and Co/El on. 
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1 2 3 4 5 6 7 
Figure 3.3 PGR confirmation of plasmid integration in E.coli and S.typhimurium. Lane 1 is 
a 561 bp product of intact €atP22 of Kcoli using primer pair AB. Lane 2 is a SSI bp product 
of attL of Kcoli integrant using primer pair AC. Lane 3 is a 479 bp product of attR of Kcoli 
integrant using primer pair BD. Lane 4 is a 100 bp DNA marker. Lane S is a 348 bp product 
of intact aUiA of S.typhimurium using primer pair EF. Lane 6 is a 346 bp product of attL of 
S.typhimurium integrant using primer pair CF. Lane & is a 470 bp product of attR of 
S.t)j^murium integrant using primer pair DE. The sequences of primers used are as follow, 
A: CGGCACACAACACTCCGAT, B: GCCAAGGATGTATAGTGAGCGAA, 
C: GGTTCGCCGATATGCTCATC, D: CAGCGGATTCGGAAAGGTCTG, 
E: ACTCATGGCGCATGGTAAACAAGA, F: ATGAGGTTGTACATAAGTGA. 
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CGGCACACAACACTCCGATGCGATCCTGACCCGCGATATGCGCAAC 
GCCCAGCGTTTTGTTAACGCCTCTACGCGTTTTACCGACGGCGGCCA 
GTTTGGTCTGGGTGCGGAAGTGGCGGTAAGCACACAAAAACTCCAC 
GCGCGTGGCCCAATGGGGCTGGAAGCACTGACCACTTACAAGTGGA 
TCGGCATTGGTGATTACACCATTCGTGCGTAAATAAAACCGGGTGAT 
GCAAAAGTAGCCATTTGATTCACAAGGCCATTGACGCATCGCCCGGT 
TAGTTTTAACCTTGTCCACCGTGATTCACGTTCGTGAACATGTCCTTT 
CAGGGCCGATATAGCTCAGTTGGTAGAGCAGCGCdnSGTMaTOC  ^
AGGTCGTAGCiTTCGACTCCTAJTATCGGCACCACiTTAAA TCAAA TACTTAC 
GTATTATTCGTGCCTTCCTTATTTTTACTGTGGGACATATTTGGGACAGAA 
GTACCAAAAATCGAGTCAATTTGTCGAGCATGTTCAGTCAGGTGATFTGG 
TGCCAGATGAGCATATCGGCGAACCNNNNNNNNNNNNNNNNNNNNN 
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNACTTCAACATTATGAAAATC 
AGCGGATTCGGAAAGGICIGAAGTGTAGCACTACAAATTGTTTTGATC 
GATACAAGCGATCAATAATGTATAAnTGATAGTTTTTATCTATATAATGCA 
TGTTAATTGATCGTTGTTACCGATCAATTTTTATTGCTGAnGCTAAGTGGT 
TrGGGACAAAAATGGGACATACAAATCTTTGCATCGGTTTGCAAGGCTTT 
GCATGTCTTTCGAAGATGGGACGTGTGAGCGCAGGTATGACGTGGTATG 
rrGTTGACTTAAAAGGTAGTTCTTATAATTCGTAATGCGAAGGTCGTAGGT 
TCGACTCCTATrATCGGCACCATTAAAATCAAATTGTTACGTAAGATCT 
TATCATTCTCCCACCAAAAAATTATCTTAATGTAACAGCTGGTGTAA 
GTAAATTCTATCAACGAAGATCAATCTTATCTACTGACCAAAAAGGC 
CTGATAGGGCTTCGCTCACTATACATCCTTGGC 
ATCGATCG represents primers A and B on the Kcoli chromosome. 
ATCGATCG represents primers C and D from pCD22PKS. 
ATCGATCG represents the 46 bp common core sequence of attL and attR. 
ATCGATCG represents nucleotide sequence originating from the KcoU chromosome. 
ATCGATCG represents nucleotide sequence of pCD22PKS. 
Figure 3.4 DNA sequences oftheP22afl£, and al//{ regions of £.co//chromosome. The left 
arm of the cmL and the right arm of the cUtR sequences were derived from the K coii 
chromosome while the left arm of the atlR and the right arm of the ML sequences were from 
the P22 phage DNA carried by pCD22PKS. 
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CHAPTER 4. BACTERIOPHAGE THERAPY: A NOVEL METHOD OF 
LYTIC BACTERIOPHAGE DELIVERY 
Ratree Piatt, Donald L. Reynolds, and Gregory J. Phillips 
ABSTRACT 
Bacteriophage therapy is a potential alternative to the use of antibiotics that has been 
applied to control bacterial infections in both humans and animals. Despite its potential, 
multiple doses are required to provide a continuous supply of phage. A gastric acid 
neutralization step is also needed when phage particles were applied orally because of the 
susceptibility of the phages to acid lysis. To solve these limitations, a lysogen of a lytic 
mutant of bacteriophage X in a non-pathogenic Escherichia coli strain was constructed for 
oral phage therapy. The lysogen of enteric origin bacteria is less susceptible to gastric acid 
than phage particles and acid neutralization should not be needed prior to treatment. The 
lysogen should also colonize in the intestinal tract and cominuously release lytic X phage that 
lyses the susceptible bacteria, thereby controlling the bacterial infection. 
Two plasmid-based site-specific recombination (SSR) systems mediated by 
bacteriophages X of E. coli and P22 of Salmonella typhimurium for integration of genes into 
the bacterial chromosome were used to construct a lysogen of a lytic bacteriophage X. The 
P22 system was used to integrate the repressor gene cl from wild type X into the chromosome 
of a non-pathogenic K coli strain at the attP22. A lytic X phage mutant, W30, encoding non­
functional cl repressor protein is incapable of lysogeny and, consequently, only lyses X-
sensitive K coli. W30 phage was mailced with an antibiotic resistant gene cassette to 
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facilitate lysogen selection. The lysogen of W30 phage demonstrated the efficiency in 
decreasing the number of X sensitive K coli. 
INTRODUCTION 
The emergence of multiple antibiotic resistant pathogenic bacteria such as 
Escherichia coli, Stcphylococcus q?.. Streptococcus Pseudomonas sp., etc., has become a 
significant problem in the attempt to control both human and animal pathogens. Clearly, 
there is a need to develop alternatives to the use of antibiotics for elimination of pathogenic 
bacteria. One suggested solution is the use of lytic bacteriophages (Barrow et al., 1998). 
Bacteriophages are bacterial viruses that are able to infect specific microbial species. 
Virulent phages lyse their hosts while temperate phages have the ability to either lyse the 
bacterial cells they infect or to integrate into the host chromosome and form a lysogen. A 
population of lysogens will, however, continue to release progeny phage into the 
environment. The progeny of phage will then repeat the infection cycle in their specific host. 
Therapeutic uses of various bacteriophages in both humans and animals have been 
applied locally, orally, and systemically to treat a wide variety of antibiotic resistant 
pathogens with great success (reviewed in Alisky et al., 1998). In more recent medical 
applications, Lang et al. (1979) applied bacteriophage therapy to treat long-term septic 
complications of orthopedic surgery involving antibiotic resistant organisms. The results 
were fiivorable in most of the reported cases. For example, topical applications of 
bacteriophages to control antibiotic-resistant staphylococcal suppurative skin infection in 
humans had been reported with "clinical improvement results" with no untreated control 
(Slopeke/a/., 1983a, 1983b, 1984,198Sa, 198Sb, 198Sc, 1987, Cisloe/a/., 1987). 
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Kochetkova et al. (1989) studied the efficacy of phage therapy of suppurative and 
inflammatory complications in oncological patients using medicinal phages manufactured by 
the Tbilisi Research Institute for Vaccine and Sera, Russia. They reported higher positive 
results from bacteriophage therapy than antibiotic treatment. The resuhs depended on 
several factors, such as type of pyoinflammatory complications, the microflora pattern of the 
purulent foci, and characteristics of the therapeutic phages. Soothill (1994) successfully 
applied bacteriophage BS24 to control Pseudomonas aeruginosa contamination of bum 
wounds that caused failure in skin isografting. 
In veterinary application. Smith and Huggins (1982) treated experimentally E. coli 
infected mice using phages. They also reported the superiority of phage therapy over 
antibiotics by showing that a single intramuscular dose of phage was more effective than 
multiple intramuscular doses of various antibiotics in curing mice of a potentially lethal 
induced infection of E. coli. Importantly, the few phage-resistant mutants of E. coli found in 
the mice were shown to be of greatly reduced virulence. Smith and Huggins (1983) also 
reported the effectiveness of phages in treating E. co//-induced diarrhea in piglets and lambs, 
and in calves (Smith et ai, 1987a). They reported that the phages multiplied rapidly and 
profusely after gaining entry to the E. co/i-infected small intestine and quickly reduced the K 
coli to numbers that were virtually harmless. Smith et al. (1987a) reported the control of 
severe E coli diarrhea in calves by a single oral dose of 10,000 phage organisms that were 
admixed with an oral inoculum of enteropathogenic E. coli. The "phage-infected" cows were 
also protected against diarrhea. Additional studies have also been performed to avoid loss of 
phage by the mammalian host defense systems that rapidly eliminate phages from the 
circulation. To avoid this limitation, Merril et al. (1996) isolated long-circulating 
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bacteriophage X. and P22 mutants that were maintained in the blood for a longer period of 
time. These phage mutants proved to have greater capability as antibacterial agents than the 
wild type phage in animals infected with lethal doses of bacteria. Barrow et al. (1998) 
applied a lytic bacteriophage to prevent septicemia and a meningitis-like infection in 
chickens caused by a Kl^ bacteremic strain of K coli. They reported a prolonged protection 
even when the phage administration was delayed until signs of disease appeared. 
Bacteriophage therapy, on the other hand, has certain limitations. These include the 
necessity to neutralize gastric acidity prior to multiple dose of oral phage administration 
because the phage particles are more susceptible to acid lysis than the target bacteria (Smith 
et al., 1987b). Unpredictable results may also be contributed to by a narrow phage host-
range, the formation of lysogens in the infected bacteria, the development of phage resistant 
bacteria, and the lack of a continuous supply of bacteriophages over the period of progressive 
bacterial infection. The goal of this study was to develop a novel and effective lytic phage 
delivery system that overcomes some of these limitations. The construction of bacterial 
strain iysogenic for a lytic phage for oral phage therapy from an enterobacteria origin should 
be able to overcome the requirements for mukiple doses of the phage as well as the gastric 
acidity neutralization due to the acid resistance in enteric bacteria (Gorden and Small, 1993). 
Bacteriophage X is the best genetically characterized E. coli phage. Naturally, X is a 
temperate phage that is able to lysogenize its DNA into the host chromosome by activity of 
the cl repressor protein. A phage mutant encoding a non-functional cl gene is essentially a 
lytic phage that is unable to form a lysogen in its susceptible host. In this study, a lysogen of 
a lytic X phage mutant was constructed in a non-pathogenic K coli strain. The lytic X. lysogen 
should be administered orally without a need for gastric acidity neutralization while ensuring 
90 
a continuous supply of the lytic phage. To construct this lysogen, lytic mutant of X phage, 
W30, which contains a non-flinctional repressor gene c/, was marked with an antibiotic 
resistant gene cassette to facilitate selection of a lysogen. Two plasmid-based site-specific 
recombination systems mediated by bacteriophages X and P22 developed in our laboratory 
(Piatt etcU. 2000; Piatt and Phillips, 2000) were applied as genetic tools to construct the 
lysogen. In vitro tests were performed to demonstrate the efficiency of the lysogens in 
decreasing the number of their susceptible hosts. 
MATERIALS AND METHODS 
Strains and plasmids. The bacterial strains, bacteriophages, and plasmids used in 
this study are listed in Table 1. 
Media and chemicals. Luria-Bertani (LB) medium (Sambrook et at., 1989) was 
used throughout the study. The concentrations of antibiotics were; ampicillin (Ap), 100 
^g/ml; chloramphenicol (Cm), 20 ^g/ml; kanamycin (Km), 30 ^g/ml; and nalidixic acid 
(Nd), 30 ^g/ml. Bacterial cultures were grown at 3T*C unless otherwise indicated. The Lac 
phenotype was demonstrated on an agar plate spread with 100 ^1 of 1% X-gal (S-bromo-4-
chloro-3-indolyl P-D-galactopyranoside). 
Techniques of recombinant DNA and bacterial genetics. Standard techniques of 
recombinant DNA were performed (Sambrook et al., 1989) for the construction of plasmid. 
Enzymes and reagents were obtained commercially and used according to the manufacturers' 
recommendations. Transformation was performed by either electroporation (Sheng et al.. 
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199S) or chemical transformation (Inoue et al.^  1990). A modification of the technique 
described by Carter and Milton (1993) was used to isolate plasmid DNA. The DNA of X and 
P22 phages were purified by using a commercial kit (BiolOl, Vista, CA). 
Polymerase chain reaction (PCR). All PCRs were performed in a total volume of 
SO ^1 in a thermocycler (Perldn Elmer Gene Amp PCR System 2400, Peridn-Elmer, Foster 
City, CA). The reactions were performed using 25 cycles of 94°C, 50®C, and 72°C, at 1 
minute each, with a 2-minute hold at 72''C at the end of the last cycle (unless otherwise 
indicated). The PCR products were visualized under ultraviolet illumination after agarose 
gel electrophoresis and ethidium bromide staining. 
Qoning of the cl repressor gene. A 1.08 Icb DNA fragment encoding X cl gene was 
amplified firom wild type X DNA by PCR (5'GCTGGAATGTGTAAGAGCGGG3' and 
5'TTGCTCAATTGTTATCAGCTATGCG3'). The amplified product was ligated to a pT-
Adv plasmid vector and transformed into ToplO cells, and selected on LB + Km + X-gal 
plate. Transformants of this plasmid (pT-AdV-cT) showed immunity to wild type X phage by 
a spot test (Maloy, 1990). pT-Adv-c/ was digested with EcoK I and a fragment containing cl 
was isolated. The eluted fragment was ligated with £coRI digested pCD22PKS, then 
transformed into TMiapirll6 with selection for Cm*^ on LB + Cm + X-gal plates and 
yielded the recombinant plasmid pCD22Pc/. Immunity of the transformants of pCD22Pc/.to 
wild type X phage was again demonstrated by a spot test. 
Chromosomal Integration of recombinant plasmid. A recA £ coli strain GP3S3 
served as host for plasmid integration. The strain was first transformed with the temperature 
sensitive helper plasmid for integration, pINT-A22, by selection for ampicillin resistance 
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(Ap*^) at SO'C. The pINT-A22 transformant was then transformed with pCD22Pc/by 
selection for Cm*^ at SO^C. GP3S3-c/ transformants were subsequently restreaked twice for 
Cm*^ at AZ'C to eliminate the helper plasmid. Finally, antibiotic resistant colonies were 
screened for ampicillin sensitivity (Ap^) to confirm loss of pINT-A22 and tested for 
immunity to X phage by spot test. The integration of pCD22Pc/ was confirmed by PCR as 
previously described by Piatt and Phillips (manuscript in preparation). 
Construction of a X W30 derivative. The Kcoli strain MFH208 carrying pMFH49 
(Henry and Cronan, Jr. 1991) was cultured in LB with Km and Cm and infected with lytic 
mutant of X phage, W30. The progeny phages were harvested and used to infect a polA K 
coli strain MFH210 to avoid transduction of pMFH49. The phages released from MFH210 
were used for lytic X phage lysogenization. 
Lytic X phage lysogenization. pAPRIL, the temperature sensitive (TS) plasmid 
encoding X Int (Piatt and Phillips, manuscript in preparation) was transformed into GP3S3-c/ 
with selection for Ap*^. The transformants were infected with a W30 phage lysate prepared 
from MFH210 and plated on LB with Ap and Km at 30°C. Single colonies were restreaked 
twice on Km plates at 42''C to eliminate the helper plasmid. The Km*^ colonies were 
screened for the release of lytic X phage by the presence of clear plaques on a lawn of 
BNN102 by spot test. The Km*^ W30 lysogen (RP2000) was PCR confirmed for the Km*^ X 
phage lysogenization at attB site. Two PCR primers designed from the right arm of the K 
coli attB site, S'CGCCGCCTGAATCGTGGTATG3' (Piatt et al. 2000), and a wild type X int 
gene, 5'ACTCGTCGCGAACCGCTTTC3' (Powell et al. 1994), were paired to amplify the 
681 bp attR region of the lysogen. 
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In vitro characterization. The nalidixic acid resistant (Nd*^) K coli strain ND16SS 
was isolated by culturing MG16SS overnight in LB +Nd broth followed by plating onto LB 
+ Nd plates to isolate single colonies. ND16S5 was used to test the efficacy of RP2000 in 
vitro. ND16SS and RP2000 were cultured overnight in LB + Nd and LB + Km broth 
respectively, then 50 |il of each culture were mixed in a tube of S ml LB broth. Fifty 
microHtres of the ND16SS culture was added into a second S ml LB broth tube and served as 
a control. The experimental and control cultures were harvested at 0,1, 2,3,4, S, 24 and 48 
hours after inoculation. Dilutions of the samples were made and 100 |il each were plated 
onto LB + Nd plates. The resuhing colonies were enumerated. One hundred microliter of 
diluted test samples were mixed with 3 ml of BNN102 containing 0.8% molten LB agar, and 
poured over LB plates. After overnight incubation at 37*0, phage plaques were enumerated. 
Three replications of the same experiment were performed and the results were averaged. 
Ten colonies of ND16SS that arose on the LB + Nd plates collected at 24 hour post 
inoculation were tested for W30 phage resistance by a spot test (Maloy, 1990). 
RESULTS 
In order to construct a lysogen of the lytic \ mutant W30, a wild-type copy of the \ cl 
gene was integrated into the chromosome of GP353 at attP22 site. GP3S3 was chosen as the 
host for W30 phage lysogenization as this recA E. coli strain is defective in homologous 
recombination, "k cl was integrated into GP3S3 by using pCD22Pc/ in combination with the 
SSR system previously described (Piatt and Phillips, manuscript in preparation). The 
integration of pCD22Pc/ was confirmed by PGR (Fig. 4.2). The resulting strain, GP3S3-c/, 
expressed the X repressor protein and, as predicted, imparted immunity to W30. Immunity 
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was demonstrated by a production of cloudy plaques when W30 was spotted on a GP3S3-c/ 
lawn. 
The lytic X phage W30 was marked with a kanamycin resistant gene cassette by 
homologous recombination with pMFH49 which contained non-essential X genes between 
the lysis genes and the right cohesive (cos) end (Henry and Cronan, Jr., 1991). pMFH49 also 
carried the X cos site, along with chloramphenicol, and kanamycin resistant genes. 
Recombination between pMFH49 and W30 generated a cointegrant with 2 cos sites. These 2 
cos sites, flanking W30 DNA and the kanamycin resistant gene, were the substrates for the X 
packaging system resulting in the generation of Km*^ W30 phage particles (Fig. 4.1). The 
Km*^ W30 phage was used to infect GP3S3-c/that had been transformed with pAPRlL, a 
plasmid encoding X Int (Piatt and Phillips, manuscript in preparation). After growth at 42''C, 
Km*^ lysogens were selected generating the W30 lysogen RP2000. Lysogenization was 
confirmed by the generation of a 681 bp PCR fragment of the atlR region of the lysogen (Fig. 
4.2). 
In order to demonstrate the effect of RP2000 on a susceptible E. coli strain, an in vitro 
test was performed. To distinguish between the phage sensitive strain (MG16SS) and 
RP2000, the nalidixic acid resistant mutant ND16SS was isolated. The results showed that 
initially the phages released from RP2000 were effective at reducing the number of ND16SS 
when compared to the control culture (Fig. 4.3). The cell numbers dropped sharply after 2 
hours post inoculation but increased after 24 hours. The number of W30 phage increased by 
6 logs within S hours but slightly decreased after 24 and 48 hours. To better understand why 
the numbers of ND16SS did not continue to decline, 10 colonies that arose on the LB Nd 
plates from samples collected at 24 hour post inoculation were tested for W30 sensitivity by 
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a spot test. All tested cultures yielded no plaques of W30 phage, demonstrating the cells had 
become phage resistant. 
DISCUSSION 
Bacteriophage therapy has been proposed as an alternative approach to combating 
multidrug resistant bacteria (Lang etal., 1979, Slopek et al., 1983-1987, Cislo et al.^ 1987, 
Kochetkova e/a/., 1989, Soothill, 1994, Barrow e/a/., 1998). Unlike antibiotics, lytic 
bacteriophages can rapidly destroy bacteria and can target specific bacteria for destruction, in 
general without any effect to other beneficial microbes. In addition, phages leave no toxic 
residue in treated animals. 
A temperate phage, such as X, normally lysogenizes its host and forms a stable 
lysogen when the expression of its lytic genes is repressed by the specific repressor protein 
cl. On the contrary, a lytic X mutant with a non-functional cl repressor gene is unable to 
lysogenize E. coli and, consequently, behaves essentially as a lytic phage. The lysogen of a 
temperate X phage releases wild type phage within a culture of bacteria. This phage is 
capable of infecting another X-sensitive host. The released phage may subsequently either 
lyse or lysogenize the new host. A mutation in the repressor gene of a temperate phage, e g., 
cl of X, renders the repressor protein unable to repress the phage replication, resulting in 
generation of a lytic mutant. Consequently, we reasoned that a lysogen of a lytic X phage 
(pT) could be constructed by providing a functional copy of cl gene in the host. As cl gene is 
autoregulated (Ptashne, 1986), a single copy of the gene is needed to avoid overexpression. 
To accomplish this we developed two SSR systems to stably integrate DNA constructs into 
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the K coli chromosome (Piatt et ai., 2000, Piatt and Phillips, manuscript in preparation). The 
stability afforded by this chromosomal integration system is also very practical if the system 
is to be applied in animal systems when antibiotic selection for plasmid maintenance cannot 
be used. Ideally, a culture of the lytic X lysogen should release lytic X phage while also 
maintaining the lysogen population. 
To obtain a lytic X lysogen, a non-pathogenic E.coli strain expressing the wild-type cl 
gene was constructed. A derivative of the plasmid vector pCD22P (Piatt and Phillips, 
manuscript in preparation) system carrying the cl gene was constructed and integrated into 
the E.coli chromosome at the attP22 site. The resulting a///'22.':pCD22Pc/ E. coli strain 
provided the functional repressor protein which, in turn, provided the opportunity for the 
lytic X phage to lysogenize at its regular attB site. In order to facilitate selection of the rare 
W30 lysogens fi'om the background of non-lysogens, the lytic X mutant was marked with an 
antibiotic resistant cassette. The protocol developed by Henry and Cronan Jr. (1991) was 
used to recombine a Km*^ cassette onto the W30 chromosome. To avoid transduction of 
kanamycin resistance by a plasmid-mediated event, a DNA polymerase I deficient (polA) 
Exoli strain, MFH210, was used to isolate the Km*^ W30. Since this strain does not support 
Co/El ori plasmid replication, it eliminated the chance of obtaining Km*^ colonies from 
plasmid transduction. The host strain BNN102, an hfl (high frequency of lysogenization) 
mutant also proved useful in these studies. This strain is deficient in protease activity that 
permits easy differentiation between X cl which forms clear plaque and wild type X which 
forms cloudy plaques (Belfort and Wulff, 1973). In cl expressing cells, all the genes of the 
infecting phage including int are repressed. The helper plasmid for integration, pAPRIL, was 
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used as it provided the A, Int protein necessary to initiate SSR. This plasmid contains a 
temperature-sensitive ori which made it possible to eliminate the vector at the non-
permissive temperature of after phage lysogenization. The use of a recA host also 
helped avoid the chance of phage integration by homologous recombination with the 
chromosomally-integrated cl gene. It also assured that the released lytic phage would not 
revert to wild type due to cl homologous recombination. 
The strain RP2000 was shown to effectively decrease the number of A.-sensitive E. 
coli in an in vitro assay shortly after inoculation. However, phage resistant mutants arose in 
the presence of a high concentration of W30 phage and multiplied back to a high number 
after 24 hours post inoculation. Smith and Huggins (1982) also reported the emergence of 
phage-resistant mutants of a pathogenic E. coli strain after lytic phage therapy in mice. The 
mutants, however, were shown to be of greatly reduced virulence. Since the bacterial strain 
ND16S5 used in these experiments is a derivative of the strain K-12, we were unable to 
demonstrate an alteration of bacterial pathogenicity. The observation that the numbers of 
lytic phage rapidly increased in a relatively short period of time in the in vitro assay also 
confirmed that the phages were replicating in the RP2000 host, as well as demonstrated the 
phage's lytic effect on the target cells. The propagation of the phage during exposure to the 
target host increases the likelihood of rapid and complete elimination of the target bacteria 
before the emergence of phage-resistant mutants. 
Although the in vitro results did not show long-term protection, in vivo experiments 
in various experimental animals will also be necessary to evaluate the applicability of oral 
therapeutic and prophylactic administration of this lytic phage lysogen in animals. The new 
model of lytic phage delivery described here could potentially be applied to other temperate 
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bacteriophages that utilize similar repressor system such as P22 phage of Salmonella 
typhimurium to cover a wider range of bacterial hosts. The use of different combinations of 
lytic phage lysogens would also cover wider host ranges. To potentially overcome the 
observed limitation of a single phage application due to the emergence of phage-resistant 
mutants, several phage types that use different receptors on the same target bacteria may be 
applied simultaneously. 
The construction of a lytic \ lysogen reported here offers another approach in the 
attempt to apply bacteriophage therapy to control multidrug-resistant bacteria. Although the 
phage-resistant bacteria will eventually develop, the current antibiotic resistant crisis 
suggests that bacteriophages may help combating deadly bacteria when no other means are 
available. 
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Table 4.1 Bacteria, bacteriophages, and plasmids involved in this study. 
Relevant Cgniinents Source or reference 
Rcnotvpe 
Kcoli 
MC4I00 X', biac Host for homologous recombination. CGSC' 
DHSa lac, recA Host for plasmidrepUcatioa Gibco, BRL, Gaittiersburg, 
MD 
jyOSa pirllS pirlI6 Ifost for R6KYor  ^plasmid replication. Piatt «r a/., 2000 
ToplO he, recA Host for pT-Adv plasniid replication. Clonetech lab. be. 
Palo Alto, CA 
MFH208 hadR Host of pMFH49 plasmid. Ifenry and Cronan, Jr. 1991 
MFH210 poiA Host for X phage replication. Henry and Cronan, Jr. 1991 
GP353 rtcA Host for lytic X lysogen construction. Phillips, G.J. (lab collection) 
BNN102 hjlA::lnIO Host for detection of c/- phage. ATCC 
ND16SS Nd"  ^ Host for in vitro test This study 
Xphage 
Wild type Wild type Phage for lytic phage construction and source Miller, 1992 
of functional repressor gene. 
W30 cr Phage for testing of the repressor protein Silhavy and Beckwith, 198S 
expression. 
Plasniid 
pT-Adv Ap  ^MCS Plasmid vector for PGR cloning Clonetech lab. Inc. 
Palo Alto, CA 
pT-Adv-c/ Ap*, Xc/ Plasmid vector carrying X c/gene This study 
PCD22PKS Cm  ^R6Kron, Plasmid vector for integration at attP22 site. Piatt and Phillips, manuscript 
a(tP2  ^MCS in preparation 
pCD22Pcf Cm  ^R6KYan, Plasmid for mtegration of X cl gene at attP22 This study 
attP22.XcI site. 
pMFH49 Cm\ Km*. Plasmid for X phage marking. Henry and Cronan, Jr. 1991 
Xcos 
pINT-K22 Km ,on , Helper plasmid for integration of plasmids at Piatt and Phillips, manuscript 
P22 int attP22 site. in preparation 
pAPRIL Ap*. on", X I'M Helper plasmid for integration of lytic X phage Piatt and Phillips, manuscript 
at aoS site. in preparation 
' EL coli Genetic Stock Center. 
^ American Type Culture Collection. 
^ Temperature sensitive origin of replication 
103 
.Cm 
COSi 
Km' 
cos 
PMFH49 
W30XDNA 
cl-
llllllf 
Recombinant 
Figure 4.1 Formation of a cointegrant by the homologous recombination between W30 and 
pMFH49 carrying X non-essential genes (Rz, R, and S) and cos site. The cointegrant carries 
2 cos sites which are substrates for X packaging machinery. The bars indicate the part of 
DNA that is packaged in Km*^ W30 X phage. 
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1 2 3 4 5 6 7 8 
Figure 4.2 PGR confinnation of the presence of the W30 Km*^ X lysogen. Lane 1 and 8 are 
100 bp molecular weight markers. Lane 2 and 3 represent the intact attB site amplification of 
the MC4100 and W30 Km*^ X lysogen DNA, respectively. In lane 3, as W30 Km*^ X forms a 
lysogen at attB site, the 494 bp attB fragment is absent. Lane 4 and 5 show the 681 bp 
fragments of the attR of X. lysogen. Lane 6 and 7 show the 479 bp fragments of the attR of 
pCD22c/ integrant. MC4100 -X lysogen and MC4100-pCD22Pc/ integrant DNA were used 
as positive control templates in lane 4 and 6, respectively. W30 Km*^ X lysogen DNA was 
used as template in lane S and 7. The primers used in lane 2 and 3 were 
5'CGCCGCCTGAATCGTGGTATG3* and 5'CACTCTCTGGCAAGCGCCTC3', lane 4 
and 5 were 5'CGCCGCCTGAATCGTGGTATG3' and 
5'ACTCGTCGCGAACCGCTTTC3', lane 6 and 7 were 
5*GCCAAGGATGTATAGTGAGCGAA3' and 5'CAGCGGATTCGGAAAGGTCTG3\ 
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logphigo 
numlMr 
(PFUAni) 
3 4 
Tkm (jr.) poit inocuiAion 
Figure 4.2 In vitro test results; The effect of RP2000 in decreasing number of X-sensitive 
cells. The control (black bars) and test (stippled bar) samples were collected at 0,1,2,3,4, 
5,24 and 48 hours after inoculation and enumerated for ND1655 on LB + nalidixic acid 
plates. Clear phage plaques from test samples were counted on a lawn of BNN102 on LB 
plates. The numbers of cell and phage counts are represented as loglO value of colony 
forming unit/ml (left) and plaque forming unit/ml (right) respectively. 
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CHAPTERS. GENERAL CONCLUSIONS 
General Summary 
Three papers are presented in this dissertation. The construction of a new genetic tool 
for K coli strain construction is described in the first paper in Chapter 2. A plasmid system 
was developed for site-specific integration into, and excision and recovery of gene constructs 
and lacZ gene fusions from an E. coli chromosome. Plasmid suicide vectors utilizing the 
origin of replication of R6KY plasmids and containing the attP sequence of bacteriophage 
X facilitate reversible integration into the K coli chromosome by site-specific recombination 
(SSR). Additional vectors permit construction of lacZ gene fusions in three possible reading 
frames for recombination with the bacterial chromosome. These suicide vectors can be 
propagated in the newly constructed K coli strains that harbor different pir alleles. Two 
helper plasmids that encode the necessary gene products for integration (Int) and excision 
(Int and Xis) were constructed. This plasmid system was shown to be a reliable and efficient 
means to integrate and subsequently recover plasmids from the E. coli atlB site. 
Chromosomal integration by SSR overcomes problems associated with gene overexpression 
on a multi-copy plasmid that may be detrimental to cell growth. It also provides a more 
accurate measurement of gene expression as monitored by a reporter gene. Integration at 
attB insures that no functional host gene is inactivated upon insertion. 
Chapter 3 presented the construction of an additional plasmid-based genetic system 
that uses the SSR machinery of bacteriophage P22 to reversibly integrate DNA constructs 
into the chromosomal P22 attachment site of K coli {attP22) or S. typhimwrium {atoA). This 
system expands the use of SSR in the construction of bacterial strains in addition to the 
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previously constructed X system. The P22 system also utilizes a conditionally replicating 
plasmid that carries the R6KY origin of replication and bacteriophage P22 attachment site. 
The P22 SSR reaction was initiated using a helper plasmid that carries the P22 int gene and 
replicates using a temperature sensitive origin of replication. Recovery of the integrated 
constructs was achieved using a second helper plasmid that carries both the P22 xis and INF 
genes. This system was demonstrated to be efficient in both integration and excision of 
plasmid vector DNA in E. coli and S. typhimurium. In combination with a previously 
constructed X SSR system, the P22 system permits integration of gene constructs at two 
bacterial chromosomal locations. 
Chapter 4 described the application of the systems reported in Chapters 2 and 3. Both 
X and P22 SSR systems were applied to construct a lysogen of lytic bacteriophage A. in E. 
coli. A lytic X phage mutant was marked with an antibiotic resistant gene to facilitate 
selection of a lysogen. To construct a lysogen of the lytic \ phage mutant, the P22 SSR 
system was applied to integrate a functional X repressor gene, cl, into the host chromosome. 
The X SSR system then applied to facilitate the lysogenization of the lytic X phage. In vitro 
tests were performed which demonstrated the high efficiency of the lytic X phage lysogen in 
decreasing the number of susceptible bacteria. This lytic phage lysogen construction strategy 
can be applied as an alternative to the use of antibiotics to control pathogenic bacterial 
infections in vivo. 
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General Discussion 
Bacteriophage therapy can be applied as an alternative to the use of antibiotics when 
the prevalence of chronic antibiotic resistant bacterial infection increases. The appearance of 
antibiotic residue in food animals also favors the biological control of bacterial infection. 
Certain problems involved with bacteriophage therapy have limited its application in the 
past. Several attempts have been made to improve the efficiency of bacteriophage therapy, 
including the selection of specific lytic phages (Barrow et al., 1998) as well as the phages 
that can survive in the blood circulation for a longer period of time (Merril et al., 1996). 
These approaches were demonstrated to improve the success of bacteriophage therapy in vivo 
as an antimicrobial agent. 
In this study, molecular biology techniques were applied to construct a lytic \ phage 
lysogen in a non-pathogenic E. coii strain. Two plasmid-based bacteriophage-mediated site-
specific recombination systems of bacteriophages X and P22 were developed. The plasmid 
vectors of the X SSR system integrated into the K coli chromosome at the attB site while 
those of the P22 system integrated at the attP22 site oiK coli and the ataA site of S. 
typhimurium chromosomes. The integration into the host chromosome initiated by these 
systems is very stable with no need for continual antibiotic selection. Both systems are very 
useful for bacterial strain construction. The reversible nature of both systems also enables 
the retrieval of the integrated genes to facilitate the study of any genetic change, e.g., 
mutation when required. The consecutive use of both systems in K coli makes it possible to 
integrate two difTerent genes of interest into two chromosomal locations. Both systems were 
also proven to work in other Salnumella serovars, e.g., S. chokraesuis, S. pullorum 
(unpublished data), even though the primary attachment sites were not identified. 
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The application of the two SSR systems provides a promising model for construction 
of new K coli and Salmcmlla live vaccines that express foreign antigens. The normal flora 
that colonizes naturally in the digestive tract may possibly be used as an expression host. 
The establishment of recombinant bacteria in the digestive tract will provide a continuous 
supply of the integrated foreign antigen. The stable gene integration in E. coli at two 
chromosomal locations expands the applicability of the system to express more than one 
foreign gene at a time. Furthermore, attenuated S. typhimurium has been successfully used to 
express heterologous antigens or fusion proteins from either bacterial, viral, or protozoan 
origin or other novel antigens, e.g., cytokines and contraceptive antigens (Doggett and 
Brown, 1996). Salmonella tends to withstand macrophage killing and confers the advantage 
of being an expressing vector with respect to the survival in the host (Ramsey et ai, 1994). 
Expression of heterologous antigens in Salmonella has shown to induce both humoral, 
especially mucosal immune responses, and cell-mediated immune responses to purified 
recombinant antigens (Doggett and Brown, 1996). If necessary, conditional expression of 
the gene product can be achieved using a different genetic regulatory system. Conditional 
expression of the inserted gene will reduce the frequency of destruction of the live bacterial 
vaccine itself by specific host defense mechanisms and also reduces the chance of host 
tolerance due to continuous exposure to the antigen (Kuby, 1994). 
In this research, both integration systems were applied to construct a lysogen of a 
lytic mutant of bacteriophage X. The X repressor gene was integrated into a non-pathogenic 
K coli chromosome by P22 SSR. To facilitate selection of the lysogen, the lytic X phage 
mutant was noarked with a kanamycin resistant gene cassette. The marked lytic X phage then 
iysogenized into the chromosome of the repressor expressing E. coli by X SSR. The in vitro 
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test demonstrated the ability of the lytic \ lysogen in decreasing number of a X-sensitive 
bacteria. This novel method of oral phage therapy may be able to solve the problem of 
requirements for muhiple doses of the phage application as well as for gastric acidity 
neutralization prior to oral phage treatment. 
Bacteriophage therapy is one of several approaches employed to combat multi-drug 
resistant bacteria. This strategy of lytic bacteriophage lysogen construction can be applied as 
a model to construct lysogens of other lytic bacteriophages to cover a wider range of 
bacterial hosts. In vivo experiments will be needed in various experimental animals to 
evaluate the applicability of this lytic phage lysogen for oral prophylactic and therapeutic 
purposes. 
Recommendations for Future Research 
This study consisted of two parts, the construction of molecular genetic tools and 
their application to construct a lytic bacteriophage lysogen. Future research will help 
strengthen their potential use. The following recommendations are made for future research; 
1. Construction of lytic X lysogen by a different approach. Lytic X phage can be constructed 
by a complete replacement of repressor gene, cl, by an antibiotic resistant cassette. The 
constructed lytic phage will contain no homologous sequence to the integrated cl gene. 
This will eliminate the chance that mutated cl of lytic phage recombine with the 
integrated cl gene by homologous recombination and return to wild type phage. The 
similar approach can be applied to construct the lytic phage lysogen. The construction of 
a lytic A, phage has already begun in our laboratory. 
I l l  
Construction of tysogens of other lytic bacteriophages. The construction strategy of the 
lytic phage iysogen can be applied to other bacteriophages to expand the target 
pathogenic bacteria host range. The bacteriophage P22 of S. typhimurium has a very 
similar site-specific integration system as in the X phage. The construction of a lytic P22 
Iysogen has already begun in our laboratory. 
Evaluate the performance of the lytic bacteriophage Iysogen in various experimental 
animak. Prior to prophylactic or therapeutic applications, the efficiency of Iysogen in the 
digestive tract should be studied as well as any possible side effects. The locations of 
intestinal colonization by Iysogen and the lytic phage release pattern should be identified. 
Various experimental animals may be used as different model for further in vivo 
applications. 
Construction of live bacterial vaccines expressing multiple foreigjft genes. The S. 
choleraesuis strain 54 carrying the K88 antigen of E. coli was successfully constructed 
using the integration system of bacteriophage X (Lee et al., unpublished data). Although 
the integration site for the X phage in S. choleraesuis was not identified, S. typhimurium 
naturally contains a specific attachment site for the bacteriophage P22, and the \ 
integration system has been shown to be able to integrate into the S. typhimurium 
chromosome (unpublished data). A vaccine oiSalmonella origin is also known to 
stimulate both humoral and cellular host defense systems. 
Applicatitm of the inteff'ation systems to control enteropathogenic E. coli infections. The 
proteins "intimins" expressed by enteropathogenic E. coli are known to facilitate the 
adherence of the bacteria to intestinal mucosa and confer pathogenicity. The intimins' 
encoded genes have been identified (McGraw et a/., 1999; Adu-bobie et al., 1998; 
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Beebakhee et aL, 1992) and can be stably integrated into a non-pathogenic E. coli or 
Salmonella by site-specific recombination. The protein expression can be regulated by 
genetic regulatory system to prevent constitutive expression that may lead to the immune 
tolerance. At least two different intimin genes can be integrated into the same bacteria by 
the consecutive application of both SSR systems. The intimins expressing cells will then 
stimulate specific IgA production and can be used for prophylactic purpose in animal. 
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